image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
1e99c0692e90d7ff9be2b92269d502ec1945e3b93c9bb7d9bada29492ecede3a.png | complex | <table><tr><td>Opioids</td><td>Crystalloid</td><td>Colloid</td><td>P value</td></tr><tr><td>Fentanyl (mcg)</td><td>25 (0.0–100)</td><td>25 (0.0–75.0)</td><td>0.52</td></tr><tr><td>Pethidine (mg)</td><td>10.3 (23.7)</td><td>4.9 (16.2)</td><td>0.17</td></tr><tr><td colspan="4">Rescue Anti-emetics</td></tr><tr... | <table><tr><td>Opioids</td><td>Crystalloid</td><td>Colloid</td><td>P value</td></tr><tr><td>Fentanyl (mcg)</td><td>25 (0.0–100)</td><td>25 (0.0–75.0)</td><td>0.52</td></tr><tr><td>Pethidine (mg)</td><td>10.3 (23.7)</td><td>4.9 (16.2)</td><td>0.17</td></tr><tr><td colspan="4">Rescue Anti-emetics</td></tr><tr><td colspan... | <table><tr><td>Anti-emetics N(%)</td><td>9 (16.9)</td><td>5 (5.3)</td><td>0.37</td></tr><tr><td colspan="4">Time of Anti-emetic administration. N (%)</td></tr><tr><td>0–30 min</td><td>2 (3.6)</td><td>3 (5.3)</td><td>0.98</td></tr><tr><td>30 min–2 hrs</td><td>5 (9.1)</td><td>2 (3.5)</td><td>0.42</td></tr><tr><td>2–24 hr... |
0443dfef8e9581ebf0fcb7ae6ab733d17ddb6c8c2b4e5fefae49c9663a3bd220.png | complex | <table><tr><td rowspan="2">Sl. no</td><td rowspan="2">Hydrophobic substrates</td><td colspan="2">Emulsification index (%)</td></tr><tr><td>24 h</td><td>168 h</td></tr><tr><td>1</td><td>n-Hexadecane</td><td>25.19 ± 0.12</td><td>22.58 ± 0.11</td></tr><tr><td>2</td><td>Sunflower oil</td><td>33.33 ± 0.87</td... | <table><tr><td rowspan="2">Sl. no</td><td rowspan="2">Hydrophobic substrates</td><td colspan="2">Emulsification index (%)</td></tr><tr><td>24 h</td><td>168 h</td></tr><tr><td>1</td><td></td><td>2</td><td>22.58 ± 0.1</td></tr></table> | <table><tr><td rowspan="2">Sl. no</td><td rowspan="2">Hydrophobic substrates</td><td colspan="2">Emulsification index (%)</td></tr><tr><td>24 h</td><td>168 h</td></tr><tr><td></td><td>n-Hexadecane</td><td>5.19 ± 0.12</td><td>1</td></tr><tr><td>2</td><td>Sunflower oil</td><td>33.33 ± 0.87</td><td>5.26 ± 0.53</td></tr><t... |
66204a87b77b5b2c1baa09f1266eb4f4236ba33be462f9e540de228e762f3dc2.png | simple | <table><tr><td>Procedure</td><td>Number</td></tr><tr><td>Abdominal aortic aneurysm repair</td><td>1</td></tr><tr><td>Abdominoperineal resection</td><td>1</td></tr><tr><td>Atrial septal defect closure</td><td>2</td></tr><tr><td>Bronchoscopy</td><td>1</td></tr><tr><td>Coronary artery bypass grafting</td><td>2</td></tr><t... | <table><tr><td>Procedure</td><td>Number</td></tr><tr><td>Abdominal aortic aneurysm repair</td><td>1</td></tr><tr><td>Abdominoperineal resection</td><td>1</td></tr><tr><td>Atrial septal defect closure</td><td>2</td></tr><tr><td>Bronchoscopy</td><td>1</td></tr><tr><td>Coronary artery bypass grafting</td><td>2</td></tr><t... | <table><tr><td>Procedure</td><td>Number</td></tr><tr><td>Transarterial chemoembolization (TACE)</td><td>1</td></tr><tr><td>Cardiac valve replacement</td><td>4</td></tr><tr><td>Varicose vein injection</td><td>2</td></tr></table> |
ce1b595b74f22e8c7c0cb0eaa2db0e8044d49ede0b85d8ecae8d14e5884ebbcc.png | complex | <table><tr><td></td><td></td><td>Base</td><td>P30</td><td>P60</td></tr><tr><td rowspan="2">Brachial systolic blood pressure (mmHg)</td><td>Before</td><td>117 ± 13</td><td>116 ± 8</td><td>116 ± 8</td></tr><tr><td>After</td><td>117 ± 10</td><td>116 ± 11</td><td>119 ± 12</td></tr><tr><td rows... | <table><tr><td></td></tr><tr><td rowspan="2">Brachial systolic blood pressure (mmHg)</td></tr><tr></tr><tr><td rowspan="2">Brachial mean arterial blood pressure (mmHg)</td></tr><tr></tr><tr><td rowspan="2">Brachial diastolic blood pressure (mmHg)</td></tr><tr></tr><tr><td rowspan="2">Brachial pulse pressure (mmHg)</td>... | <table><tr><td></td><td>Base</td><td>P30</td><td>P60</td></tr><tr><td>Before</td><td>117 ± 13</td><td>116 ± 8</td><td>116 ± 8</td></tr><tr><td>After</td><td>117 ± 10</td><td>116 ± 11</td><td>119 ± 12</td></tr><tr><td>Before</td><td>90 ± 10</td><td>92 ± 9</td><td>92 ± 9</td></tr><tr><td>After</td><td>91 ± 8</td><td>89 ±... |
0b51b8b6ecce1a6ee0879972ed81a355d651f5730703428576c98c05359b9072.png | simple | <table><tr><td>Climate/geography‡</td><td>PC1</td><td>PC2</td><td>PC3</td><td>DRYWT</td><td>HT</td><td>HEAD</td><td>LFRATIO</td><td>LFCOL</td><td>LFPUB</td><td>HABIT</td><td>AWNS</td><td>GERM</td></tr><tr><td>MAT</td><td>0.08</td><td>−0.20</td><td>0.48</td><td>0.09</td><td>0.09</td><td>−0.40</td><td>0... | <table><tr><td>Climate/geography‡</td><td>PC1</td><td>PC2</td><td>PC3</td><td>DRYWT</td><td>HT</td><td>HEAD</td><td>LFRATIO</td><td>LFCOL</td><td>LFPUB</td><td>HABIT</td><td>AWNS</td><td>GERM</td></tr><tr><td>MAT</td><td>0.08</td><td>−0.20</td><td>0.48</td><td>0.09</td><td>0.09</td><td>−0.40</td><td>0.53</td><td>−0.16<... | <table><tr><td>MAP</td><td>0.35</td><td>0.19</td><td>−0.47</td><td>0.31</td><td>0.10</td><td>0.15</td><td>−0.48</td><td>0.25</td><td>−0.39</td><td>−0.41</td><td>0.26</td><td>0.06</td></tr><tr><td>MSP</td><td>0.37</td><td>0.19</td><td>−0.50</td><td>0.32</td><td>0.09</td><td>0.18</td><td>−0.51</td><td>0.26</td><td>−0.43<... |
836f206753c2e4e62641384064809bf260232a51c0d30a05c8294c1f9cfc661b.png | simple | <table><tr><td></td><td>SCC (n = 395)</td><td>AC (n = 95)</td><td>p-value</td></tr><tr><td>Male</td><td>317(80.3)</td><td>71(74.7)</td><td>0.23</td></tr><tr><td>Age</td><td></td><td></td><td></td></tr><tr><td>< 60</td><td>195(49.4)</td><td>32(33.7)</td><td>0.006</td></tr><tr><td>60-69</td><td>118(29.9)</td><td>26(27... | <table><tr><td></td><td>SCC (n = 395)</td><td>AC (n = 95)</td><td>p-value</td></tr><tr><td>Male</td><td>317(80.3)</td><td>71(74.7)</td><td>0.23</td></tr><tr><td>Age</td><td></td><td></td><td></td></tr><tr><td>< 60</td><td>195(49.4)</td><td>32(33.7)</td><td>0.006</td></tr><tr><td>60-69</td><td>118(29.9)</td><td>26(27.4)... | <table><tr><td>T3</td><td>201(50.9)</td><td>51(53.7)</td><td>n.s.</td></tr><tr><td>T4</td><td>73(18.5)</td><td>15(15.8)</td><td>n.s.</td></tr><tr><td>N+</td><td>198(50.1)</td><td>48(50.5)</td><td>n.s.</td></tr><tr><td>M1</td><td>83(22.0)</td><td>28(32.2)</td><td>0.04</td></tr></table> |
5770135ac2be8f0a3fa3f75033901584f4a2c750b353a75f2c2966ad154bc734.png | complex | <table><tr><td rowspan="3"></td><td rowspan="3"></td><td colspan="2"><i>Treatment</i></td><td rowspan="3"><i>P</i></td></tr><tr><td><i>LNG-IUD</i></td><td><i>NETA</i></td></tr><tr><td><i>n (%)</i></td><td><i>n (%)</i></td></tr><tr><td>Initial Mens </td><td>HMB</td><td> 30 (%100)</td><td>30 (%100)</td><td>1,000</td></tr... | <table><tr><td rowspan="3"></td><td rowspan="3"></td><td colspan="2">Treatment</td><td rowspan="3">P</td></tr><tr><td>LNG-IUD</td><td>NETA</td></tr><tr><td>n (%)</td><td>n (%)</td></tr><tr><td>Initial Mens</td><td>HMB</td><td>30 (%100)</td><td>30 (%100)</td><td>1,000</td></tr><tr><td rowspan="6">3-6. months Mens</td><t... | <table><tr><td rowspan="3">3-6. months Mens</td><td>Amenorrhea</td><td>12 (%44,4)</td><td>1 (%5,6)</td><td>0,006**</td></tr><tr><td>●Normal Cycle</td><td>2 (%7,4)</td><td>6 (%33,3)</td><td>0,045*</td></tr><tr><td>●Oligomenorrhea</td><td>5 (%18,5)</td><td>2 (%11,1)</td><td>0,684</td></tr></table> |
1ea2f66d7c7d05d218468f8e4d057433a12fcd1de2efd0e2f38e795c1eb1b5a3.png | complex | <table><tr><td colspan="3">Population</td><td colspan="4">Genomic region</td><td rowspan="2">Number of windows</td><td rowspan="2">Minimum<i>P</i><sub><i>perm</i></sub></td><td rowspan="2">RefSeq genes</td></tr><tr><td>ID</td><td>Name</td><td>Cluster</td><td>Chr</td><td>Begin (bp)</td><td>End (bp)</td><td>Length (bp)</... | <table><tr><td colspan="3">Population</td><td colspan="4">Genomic region</td><td rowspan="2">Number of windows</td><td rowspan="2">MinimumPperm</td><td rowspan="2">RefSeq genes</td></tr><tr><td>ID</td><td>Name</td><td>Cluster</td><td>Chr</td><td>Begin (bp)</td><td>End (bp)</td><td>Length (bp)</td></tr></table> | <table><tr><td>ITU</td><td>Telugu</td><td>A</td><td>10</td><td>132,953,074</td><td>133,048,305</td><td>95,232</td><td>189</td><td>0.013</td><td>TCERG1L</td></tr><tr><td>PJL</td><td>Punjabi</td><td>A</td><td>13</td><td>20,001,572</td><td>20,181,691</td><td>180,120</td><td>28</td><td>0.044</td><td>TPTE2</td></tr></table> |
480a2319a5fab0727be5cc3c81710bef7381d7812cfeb99add1f6d4008b28a85.png | simple | <table><tr><td>Component</td><td><i>M. indicus</i></td><td><i>R. oryzae</i></td></tr><tr><td>Biomass (g/L)</td><td>4.7 ± 0.2</td><td>4.0 ± 0.1</td></tr><tr><td>Biomass yield (<i>g</i>/<i>g</i> sugars consumed)</td><td>0.25 ± 0.01</td><td>0.28 ± 0.00</td></tr><tr><td>Protein <sup>1</sup></td><td>0.40... | <table><tr><td>Component</td></tr><tr><td>Biomass (g/L)</td></tr><tr><td>Biomass yield (g/g sugars consumed)</td></tr><tr><td>Protein 1</td></tr><tr><td>Total lipids 1</td></tr><tr><td>AIM 2 yield 1</td></tr></table> | <table><tr><td>M. indicus</td><td>R. oryzae</td></tr><tr><td>4.7 ± 0.2</td><td>4.0 ± 0.1</td></tr><tr><td>0.25 ± 0.01</td><td>0.28 ± 0.00</td></tr><tr><td>0.40 ± 0.01</td><td>0.51 ± 0.07</td></tr><tr><td>0.098 ± 0.011</td><td>0.044 ± 0.007</td></tr><tr><td>0.31 ± 0.01</td><td>0.34 ± 0.01</td></tr></table> |
3541167529bd63db2c91cf80ee299ff1deeed9a6e6fce4f43ceff76334a23c52.png | complex | <table><tr><td></td><td colspan="3">Raw meats</td><td colspan="3">Cooked meats</td></tr><tr><td>Fatty acids<sup>A</sup></td><td>DCCOC</td><td>DCCOM</td><td>DCCOH</td><td>DCCOC</td><td>DCCOM</td><td>DCCOH</td></tr><tr><td>MC (%)</td><td>70.7 ± 0.6</td><td>72.0 ± 0.6</td><td>72.3 ± 0.5</td><td>61.6 ± ... | <table><tr><td></td><td colspan="3">Raw meats</td><td colspan="3">Cooked meats</td></tr><tr><td>Fatty acidsA</td><td>DCCOC</td><td>DCCOM</td><td>DCCOH</td><td>DCCOC</td><td>DCCOM</td><td>DCCOH</td></tr><tr><td>MC (%)</td><td>70.7 ± 0.6</td><td>72.0 ± 0.6</td><td>72.3 ± 0.5</td><td>61.6 ± 1.0</td><td>59.7 ± 1.6</td><td>... | <table><tr><td>IA</td><td>0.5 ± 0.0</td><td>0.5 ± 0.0</td><td>0.5 ± 0.0</td><td>0.6 ± 0.0</td><td>0.5 ± 0.0</td><td>0.5 ± 0.0</td></tr><tr><td>IT</td><td>1.2 ± 0.1</td><td>1.3 ± 0.1</td><td>1.1 ± 0.0</td><td>1.3 ± 0.0</td><td>1.2 ± 0.0</td><td>1.1 ± 0.0</td></tr><tr><td>h/H</td><td>1.9 ± 0.1</td><td>2.0 ± 0.1</td><td>2... |
bb2b7adc507b901b216a765957708b959c01c45907c17ff5c193abb4e76fc06e.png | simple | <table><tr><td><i>α</i></td><td><i>EP</i> selection</td><td>Leuk1</td><td>Lung1</td><td>Leuk2</td><td>SRBCT</td><td>Breast</td><td>Lung2</td><td>DLBCL</td><td>Cancers</td><td>GCM</td><td>Average</td></tr><tr><td>No adjustment</td><td>Formula (11)</td><td>94.12</td><td>84.38</td><td>93.33</td><td>95.00</td><td>90.0... | <table><tr><td>α</td><td>EP selection</td><td>Leuk1</td><td>Lung1</td><td>Leuk2</td><td>SRBCT</td><td>Breast</td><td>Lung2</td><td>DLBCL</td><td>Cancers</td><td>GCM</td><td>Average</td></tr><tr><td>No adjustment</td><td>Formula (11)</td><td>94.12</td><td>84.38</td><td>93.33</td><td>95.00</td><td>90.00</td><td>100.00</t... | <table><tr><td>α</td><td>EP selection</td><td>Leuk1</td><td>Lung1</td><td>Leuk2</td><td>SRBCT</td><td>Breast</td><td>Lung2</td><td>DLBCL</td><td>Cancers</td><td>GCM</td><td>Average</td></tr><tr><td>0.05</td><td>Formula (11)</td><td>94.12</td><td>84.38</td><td>100</td><td>100</td><td>93.33</td><td>98.51</td><td>90.00</t... |
1fb6775defb21104ee18afd76ea86411f17b38155c9fed95fd8b299de2ff94e5.png | simple | <table><tr><td>Gene (total SNPs)</td><td>SNP</td><td>Minor allele frequency</td><td>BODE score</td><td>Post-BD FEV<sub>1</sub></td><td>Maximum work</td><td>USCD SOBQ score</td></tr><tr><td><i>GSTP1 </i>(7)</td><td>rs6120205' genomic</td><td>0.083</td><td>0.003</td><td></td><td></td><td></td></tr><tr><td></td><td>rs1122... | <table><tr><td>Gene (total SNPs)</td><td>SNP</td><td>Minor allele frequency</td><td>BODE score</td><td>Post-BD FEV1</td><td>Maximum work</td><td>USCD SOBQ score</td></tr></table> | <table><tr><td>GSTP1 (7)</td><td>rs6120205' genomic</td><td>0.083</td><td>0.003</td><td></td><td></td><td></td></tr><tr><td></td><td>rs112278843' genomic</td><td>0.073</td><td></td><td>0.003</td><td>0.02</td><td></td></tr><tr><td>SFTPB (5)</td><td>--*</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>SERPIN... |
a8934ca51f73bc4da753c73981529e2c989cc2cbcc2e996d6607fb89153f38a7.png | complex | <table><tr><td>Date of DNA extraction</td><td>OTUs</td><td>Abundance (%)</td></tr><tr><td rowspan="7">17 July 2014</td><td><i>Aerococcus</i></td><td>14</td></tr><tr><td>Dermabacteraceae</td><td>12</td></tr><tr><td><i>Micrococcus</i></td><td>10</td></tr><tr><td><i>Enhydrobacter</i></td><td>9</td></tr><tr><td><i>Leuconos... | <table><tr><td>Date of DNA extraction</td><td>OTUs</td><td>Abundance (%)</td></tr><tr><td rowspan="7">17 July 2014</td><td>Aerococcus</td><td>14</td></tr><tr><td>Dermabacteraceae</td><td>12</td></tr><tr><td>Micrococcus</td><td>10</td></tr><tr><td>Enhydrobacter</td><td>9</td></tr><tr><td>Leuconostoc</td><td>6</td></tr><... | <table><tr><td rowspan="2">26 March 2015</td><td>Methylobacterium komagatae</td><td>67</td></tr><tr><td>Methylobacterium</td><td>6</td></tr></table> |
da4ea20981348c8e9f118dc25e5fb0d842965e34fbcd89b5c081fb8fb2b649d7.png | complex | <table><tr><td rowspan="2"></td><td>Aboriginal and/or Torres Strait Islander</td><td>Non-Indigenous Australian</td><td rowspan="2">P value</td></tr><tr><td>N = 174</td><td>N = 1210</td></tr><tr><td>Age (years)</td><td>37.4</td><td>65.1</td><td rowspan="2"><0.001</td></tr><tr><td>(Median (IQR))</td><td>(26.9 – ... | <table><tr><td rowspan="2"></td><td>Aboriginal and/or Torres Strait Islander</td><td>Non-Indigenous Australian</td><td rowspan="2">P value</td></tr><tr><td>N = 174</td><td>N = 1210</td></tr><tr><td>Age (years)</td><td>37.4</td><td>65.1</td><td rowspan="2"><0.001</td></tr><tr><td>(Median (IQR))</td><td>(26.9 – 49.1)</td... | <table><tr><td rowspan="2"></td><td>Aboriginal and/or Torres Strait Islander</td><td>Non-Indigenous Australian</td><td rowspan="2">P value</td></tr><tr><td>N = 174</td><td>N = 1210</td></tr><tr><td>LVEF <30%</td><td>3.4</td><td>2.1</td><td rowspan="2">0.249</td></tr><tr><td>(%, 95% CI)</td><td>(1.3 – 7.4)</td><td>(1.3 ... |
035389cdd96d892eaf072068f93e476fbb0c545fb99dacd8789aa31cd31cb5c6.png | complex | <table><tr><td></td><td></td><td colspan="3">Diabetic children</td><td colspan="2">School children</td><td></td><td></td><td></td></tr><tr><td>Scale</td><td>No.items</td><td colspan="3"></td><td colspan="2"></td><td>F</td><td>d.f</td><td>p-value</td></tr><tr><td></td><td></td><td>n</td><td>mean ± SD</td><td>α... | <table><tr><td></td><td></td><td colspan="3">Diabetic children</td><td colspan="2">School children</td><td></td><td></td><td></td></tr><tr><td>Scale</td><td>No.items</td><td colspan="3"></td><td colspan="2"></td><td>F</td><td>d.f</td><td>p-value</td></tr><tr><td></td><td></td><td>n</td><td>mean ± SD</td><td>α</td><td>n... | <table><tr><td></td><td></td><td colspan="3">Diabetic children</td><td colspan="2">School children</td><td></td><td></td><td></td></tr><tr><td>Scale</td><td>No.items</td><td colspan="3"></td><td colspan="2"></td><td>F</td><td>d.f</td><td>p-value</td></tr><tr><td></td><td></td><td>n</td><td>mean ± SD</td><td>α</td><td>n... |
16d4f5c51e6b25350bc32b15875f27fb59b5848354974788a4de91c938ff3084.png | simple | <table><tr><td></td><td>Overall Injury Risk (RP1) <sup>1</sup></td><td>Ankle Injury Severity (RP2) <sup>1</sup></td><td>Knee Injury Severity (RP3) <sup>1</sup></td><td>Injuries Are Preventable (OE1) <sup>2</sup></td><td>FIFA 11+ Prevents Injuries (OE2) <sup>2</sup></td><td>I Understand the FIFA 11+ (TSE1) <sup>3</sup><... | <table><tr><td></td><td>Overall Injury Risk (RP1) 1</td><td>Ankle Injury Severity (RP2) 1</td><td>Knee Injury Severity (RP3) 1</td><td>Injuries Are Preventable (OE1) 2</td><td>FIFA 11+ Prevents Injuries (OE2) 2</td><td>I Understand the FIFA 11+ (TSE1) 3</td><td>I Can Use the FIFA 11+ (TSE2) 3</td><td>Intention to Use t... | <table><tr><td>INT</td><td>0.09</td><td>0.13</td><td>0.55</td><td>0.13</td><td>−0.24</td><td>0.84 *</td><td>0.89 *</td><td>1.00</td></tr></table> |
7691e4f85608a5d643419ac5716f32306e0b82c02460bfb69f1e066b78a9c61d.png | simple | <table><tr><td> </td><td>Number of patients</td><td>Percentage</td></tr><tr><td>OCD Group</td><td>135</td><td>75.4%</td></tr><tr><td>Non-OCD anxiety disorders group</td><td>44</td><td>24.6%</td></tr></table> | <table><tr><td></td><td>Number of patients</td><td>Percentage</td></tr></table> | <table><tr><td>OCD Group</td><td>135</td><td>75.4%</td></tr><tr><td>Non-OCD anxiety disorders group</td><td>44</td><td>24.6%</td></tr></table> |
1b71195b62bc35fa7c6a6a7d92ee25414b0428c2f5791960fbc60cb71dbc784a.png | simple | <table><tr><td>Rupintrivir concn (μM) at final passage or control treatment</td><td>Clone no.</td><td>Mean EC<sub>50</sub> ± SD<sup><i>a</i></sup> (μM)</td><td>Fold change in sensitivity<sup><i>b</i></sup></td><td>Amino acid substitution(s) in protease</td></tr><tr><td>20</td><td>1</td><td>14.3 ± 1.... | <table><tr><td>Rupintrivir concn (μM) at final passage or control treatment</td><td>Clone no.</td><td>Mean EC50 ± SDa (μM)</td><td>Fold change in sensitivityb</td><td>Amino acid substitution(s) in protease</td></tr><tr><td>20</td><td>1</td><td>14.3 ± 1.7</td><td>10.9</td><td>A105V/I109V</td></tr><tr><td></td><td>2</td>... | <table><tr><td>15</td><td></td><td> ± 1.9</td><td>6.5</td><td>/I109V</td></tr><tr><td></td><td>2</td><td>14.3 ± 1.3</td><td>10.9</td><td>A105V/I109V</td></tr><tr><td></td><td>3</td><td>6.9 ± 1.7</td><td>5.3</td><td>I109V</td></tr><tr><td>10</td><td>1</td><td>6.6 ± 2.4</td><td>5.0</td><td>I109V</td></tr><tr><td></td><td... |
b60866271a26a0c303dffdcad1a13c7050029f8b7431fdb171292c5190fb7a6b.png | complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Number (%)</td><td colspan="2">BAI<sup>a</sup> score n (%)</td><td rowspan="2"><i>p</i>-value<sup>*</sup></td></tr><tr><td><22</td><td>≥22</td></tr><tr><td>Age (years)</td><td></td><td></td><td></td><td>0.493</td></tr><tr><td> 10–19</td><td>208(18.2... | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Number (%)</td><td>BAIa score n (%)</td></tr><tr><td><22</td></tr><tr><td>Age (years)</td><td></td><td></td></tr><tr><td>10–19</td><td>208(18.2)</td><td>174(83.7)</td></tr><tr><td>20–29</td><td>858(75.2)</td><td>727(84.7)</td></tr><tr><td>≥ 30</td><td>75(6.6)</td>... | <table><tr><td>BAIa score n (%)</td><td rowspan="2">p-value*</td></tr><tr><td>≥22</td></tr><tr><td></td><td>0.493</td></tr><tr><td>34(16.3)</td><td></td></tr><tr><td>131(15.3)</td><td></td></tr><tr><td>8(10.7)</td><td></td></tr><tr><td></td><td>0.718</td></tr><tr><td>148(15.0)</td><td></td></tr><tr><td>25(16.1)</td><td... |
e6a0fa769c9661c6021c2d7067ed55f7613e9998be7df4e38d4709cf9634175b.png | simple | <table><tr><td>Type</td><td>% Miss in positive</td><td>% Miss in random</td></tr><tr><td>All features</td><td>83%</td><td>85%</td></tr><tr><td>Gene expression</td><td>15–27%</td><td>24–43%</td></tr><tr><td>GO</td><td>39–66%</td><td>40–54%</td></tr></table> | <table><tr><td>Type</td><td>% Miss in positive</td></tr><tr><td>All features</td><td>83%</td></tr><tr><td>Gene expression</td><td>15–27%</td></tr><tr><td>GO</td><td>39–66%</td></tr></table> | <table><tr><td>% Miss in random</td></tr><tr><td>85%</td></tr><tr><td>24–43%</td></tr><tr><td>40–54%</td></tr></table> |
aabbe9c9bbd02c7ba40d85e23f626d244c387faea4c99a65cf6b3d68ab6ce4d6.png | simple | <table><tr><td>Barriers to carrying out PU</td><td>Risk assessment number (%)</td><td>Documentation number (%)</td><td>Prevention number (%)</td></tr><tr><td>Total number of respondents</td><td>194 (100)</td><td>194 (100)</td><td>194 (100)</td></tr><tr><td>Lack of time</td><td>32 (23.7)</td><td>46 (34.1)</td><td>33 (24... | <table><tr><td>Barriers to carrying out PU</td><td>Risk assessment number (%)</td><td>Documentation number (%)</td></tr><tr><td>Total number of respondents</td><td>194 (100)</td><td>194 (100)</td></tr><tr><td>Lack of time</td><td>32 (23.7)</td><td>46 (34.1)</td></tr><tr><td>Unstable patient</td><td>17 (12.6)</td><td>16... | <table><tr><td>Prevention number (%)</td></tr><tr><td>194 (100)</td></tr><tr><td>33 (24.4)</td></tr><tr><td>24 (17.8)</td></tr><tr><td>22 (16.3)</td></tr><tr><td>20 (14.8)</td></tr><tr><td>19 (14.1)</td></tr><tr><td>14 (10.4)</td></tr><tr><td>13 (9.6)</td></tr><tr><td>0 (0)</td></tr><tr><td>0 (0)</td></tr><tr><td>0 (0)... |
3f5fdb3d8711e72b8a4ea67fdbfed16a0b11b30128d8d981e5a3dbfac3cf7b03.png | complex | <table><tr><td rowspan="2">Label</td><td rowspan="2">Volume</td><td rowspan="2"><i>t</i>-value</td><td colspan="3">Peak activation (LPI)</td></tr><tr><td>x</td><td>y</td><td>z</td></tr><tr><td>Left Thalamus</td><td>342</td><td>3.92</td><td>-9</td><td>6</td><td>12</td></tr><tr><td>Right Inferior Parietal Lobule</td><td>... | <table><tr><td rowspan="2">Label</td><td rowspan="2">Volume</td><td rowspan="2">t-value</td><td colspan="3">Peak activation (LPI)</td></tr><tr><td>x</td><td>y</td><td>z</td></tr><tr><td>Left Thalamus</td><td>342</td><td>3.92</td><td>-9</td><td>6</td><td>12</td></tr><tr><td>Right Inferior Parietal Lobule</td><td>208</td... | <table><tr><td rowspan="2">Label</td><td rowspan="2">Volume</td><td rowspan="2">t-value</td><td colspan="3">Peak activation (LPI)</td></tr><tr><td>x</td><td>y</td><td>z</td></tr><tr><td>Left Precuneus</td><td>179</td><td>3.59</td><td>3</td><td>−69</td><td>48</td></tr><tr><td>Right Middle Frontal Gyrus</td><td>137</td><... |
5838fa17a8a376a074ea40341781a3fc7ddd8e03f0b8577524104104fdbd0636.png | simple | <table><tr><td>Sites</td><td>Gender</td><td>L<sub>t</sub>(cm)</td><td>L<sub>f</sub>(cm)</td><td>W<sub>t</sub>(g)</td><td>W<sub>g</sub>(g)</td><td>GSI</td></tr><tr><td>Reference (A1)</td><td>Female</td><td>29.85 ± 2.72*</td><td>26.29 ± 2.98*</td><td>283.45 ± 57.34*</td><td>7.936 ± 0.361</td><td>2.68 ... | <table><tr><td>Sites</td><td>G</td><td>Lt</td><td>Lf(cm)</td><td>Wt</td><td>Wg(g</td><td></td></tr></table> | <table><tr><td></td><td>ender</td><td>(cm)</td><td></td><td>(g)</td><td>)</td><td>GSI</td></tr><tr><td>Reference (A1)</td><td>Female</td><td>29.85 ± 2.72*</td><td>26.29 ± 2.98*</td><td>283.45 ± 57.34*</td><td>7.936 ± 0.361</td><td>2.68 ± 0.26*</td></tr><tr><td></td><td>Male</td><td>28.85 ± 2.81*</td><td>27.29 ± 2.21*</... |
49f431fa15909bd5203de7f7fb0c3856ad4f5efaaf910df9d4a9cbaedaa66e44.png | complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="3">Prevalence</td><td colspan="3">Incidence</td></tr><tr><td>No.</td><td>%</td><td>Weighted<sup>a</sup> (%)</td><td>No.</td><td>%</td><td>Weighted<sup>a</sup> (%)</td></tr><tr><td colspan="7">Age group</td></tr><tr><td>0–24</td><td>160,382</td><td>26.9</t... | <table><tr><td rowspan="2">Characteristic</td><td colspan="3">Prevalence</td><td colspan="3">Incidence</td></tr><tr><td>No.</td><td>%</td><td>Weighteda (%)</td><td>No.</td><td>%</td><td>Weighteda (%)</td></tr><tr><td colspan="7">Age group</td></tr><tr><td>0–24</td><td>160,382</td><td>26.9</td><td>33.8</td><td>166,840</... | <table><tr><td>Worker</td><td>45,021</td><td>7.5</td><td>8.7</td><td>45,004</td><td>7.6</td><td>8.8</td></tr><tr><td>Farmer</td><td>271,068</td><td>45.4</td><td>38.6</td><td>270,916</td><td>45.5</td><td>38.8</td></tr><tr><td>Employee</td><td>46,676</td><td>7.8</td><td>9.8</td><td>46,674</td><td>7.8</td><td>9.9</td></tr... |
767b2d5b381c7fb306c1393e699fce1a7058393db9515ee18364c998c912b9c9.png | complex | <table><tr><td rowspan="2">HPV genotype</td><td colspan="4">Age (Years)Frequency (%)</td><td rowspan="2">Total Frequency (%)</td></tr><tr><td>< 40</td><td>40–49</td><td>50–59</td><td>> 60</td></tr><tr><td>6</td><td>0 (0%)</td><td>0 (0%)</td><td>1 (100.0%)</td><td>0 (0%)</td><td>1 (100%)</td></tr><tr><... | <table><tr><td rowspan="2">HPV genotype</td><td colspan="4">Age (Years)Frequency (%)</td><td rowspan="2">Total Frequency (%)</td></tr><tr><td>< 40</td><td>40–49</td><td>50–59</td><td>> 60</td></tr><tr><td>6</td><td>0 (0%)</td><td>0 (0%)</td><td>1 (100.0%)</td><td>0 (0%)</td><td>1 (100%)</td></tr><tr><td>16</td><td>7 (6... | <table><tr><td rowspan="2">HPV genotype</td><td colspan="4">Age (Years)Frequency (%)</td><td rowspan="2">Total Frequency (%)</td></tr><tr><td>< 40</td><td>40–49</td><td>50–59</td><td>> 60</td></tr><tr><td>56</td><td>0 (0%)</td><td>0 (0%)</td><td>2 (50.0%)</td><td>2 (50.0%)</td><td>4 (100%)</td></tr><tr><td>68</td><td>0... |
fd890d57bec65f27c901a27b47cc3852d5ac03ab22c9010e644f7d64475237f6.png | simple | <table><tr><td>Variables</td><td>Resource</td><td>Year</td><td>Operating institution</td></tr><tr><td>The number of general hospitals (per 100,000 persons)</td><td>Survey of Medical Institutions,</td><td>2002</td><td>Ministry of Health, Labor and welfare</td></tr><tr><td>The number of beds in hospital (per 100,000 pers... | <table><tr><td>Variables</td><td>Resource</td><td>Year</td><td>Operating institution</td></tr><tr><td>The number of general hospitals (per 100,000 persons)</td><td>Survey of Medical Institutions,</td><td>2002</td><td>Ministry of Health, Labor and welfare</td></tr><tr><td>The number of beds in hospital (per 100,000 pers... | <table><tr><td>The number of families in which the elderly were living alone (per 100 households with person 65 years or older)</td><td>Population Census</td><td>2002</td><td>Ministry of Public Management, Home Affairs, Posts and Telecommunications</td></tr><tr><td>Dwelling rooms (per dwelling)</td><td>Population Censu... |
2b8100702e771dc0c4a47c870f453c5dd57da7e982ec8e80d57dee5d2e0ec864.png | simple | <table><tr><td>Data set name</td><td>Number of patients</td><td>Microarray type</td><td>Outcome</td></tr><tr><td>Chin [72]</td><td>130</td><td>Affymetrix GeneChip Human Genome U133A Array Set</td><td>Disease specific survival (Event = death from breast cancer)</td></tr><tr><td>Miller [73]</td><td>251</td><td>Affymetrix... | <table><tr><td>Data set name</td><td>Number of patients</td><td>Microarray type</td><td>Outcome</td></tr><tr><td>Chin [72]</td><td>130</td><td>Affymetrix GeneChip Human Genome U133A Array Set</td><td>Disease specific survival (Event = death from breast cancer)</td></tr><tr><td>Miller </td><td>2</td><td>Affymetrix GeneC... | <table><tr><td>Data set name</td><td>Number of patients</td><td>Microarray type</td><td>Outcome</td></tr><tr><td>[73]</td><td>51</td><td> U133 Array Set</td><td>ancer)</td></tr><tr><td>Pittman [74]</td><td>158</td><td>Affymetrix GeneChip Human Genome U95av2 Array Set</td><td>Overall survival (Even t = death from breast... |
240d199d1770abd0c569ac864b45ef05767037db137e281f45dea299bb6d99eb.png | simple | <table><tr><td></td><td>B</td><td>Se</td></tr><tr><td>Intercept</td><td>0.23</td><td>0.16</td></tr><tr><td>Quality aspects:</td><td></td><td></td></tr><tr><td> Total quality score</td><td>0.75</td><td>0.19</td></tr><tr><td> Adjustment for confounders at study level</td><td>-2.34</td><td>0.81</td></tr><tr><td> Culturall... | <table><tr><td></td><td>B</td><td>Se</td></tr><tr><td>Intercept</td><td>0.23</td><td>0.16</td></tr><tr><td>Quality aspects:</td><td></td><td></td></tr><tr><td>Total quality score</td><td>0.75</td><td>0.19</td></tr><tr><td>Adjustment for confounders at study level</td><td>-2.34</td><td>0.81</td></tr><tr><td>Culturally a... | <table><tr><td>Length of reference period of use</td><td>-0.15</td><td>0.26</td></tr><tr><td>Background immigrant groups a</td><td></td><td></td></tr><tr><td>European</td><td>1.69</td><td>0.92</td></tr><tr><td>African</td><td>0.14</td><td>0.77</td></tr><tr><td>Asian</td><td>0.92</td><td>0.56</td></tr><tr><td>(South/cen... |
b4e16ef7b4c7eac776e6d07ad90c495cd776c4a89af997b52361ba8fee5bb5c2.png | simple | <table><tr><td>Impact Category-</td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td><td>Group 5</td><td>Group 6</td></tr><tr><td>Non-renewable, fossil</td><td>0.224</td><td>0.219</td><td>0.215</td><td>0.212</td><td>0.207</td><td>0.198</td></tr><tr><td>Renewable, biomass</td><td>1.04</td><td>1.04</td><td... | <table><tr><td>Impact Category-</td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td><td>Group 5</td><td>Group 6</td></tr><tr><td>Non</td><td>0</td><td>0.2</td><td>0.215</td><td>0.212</td><td></td><td>0.</td></tr></table> | <table><tr><td>Impact Category-</td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td><td>Group 5</td><td>Group 6</td></tr><tr><td>-renewable, fossil</td><td>.224</td><td>19</td><td></td><td></td><td>0.207</td><td>198</td></tr><tr><td>Renewable, biomass</td><td>1.04</td><td>1.04</td><td>1.04</td><td>1.04<... |
12705bb2554428da651b54c4ffcac707631b91b256d793394d4c9b06fb1d73c6.png | complex | <table><tr><td rowspan="2">Sample no.</td><td colspan="2">TDS (mg/L)</td><td colspan="2">pH</td><td colspan="2">Conductivity (Ds/m)</td></tr><tr><td>Before desalination</td><td>After desalination</td><td>Before desalination</td><td>After desalination</td><td>Before desalination</td><td>After desalination</td></tr><tr><... | <table><tr><td rowspan="2">Sample no.</td><td colspan="2">TDS (mg/L)</td><td colspan="2">pH</td><td colspan="2">Conductivity (Ds/m)</td></tr><tr><td>Before desalination</td><td>After desalination</td><td>Before desalination</td><td>After desalination</td><td>Before desalination</td><td>After desalination</td></tr></tab... | <table><tr><td>Sample A-B</td><td>320</td><td>40</td><td>7.60</td><td>7.32</td><td>1</td><td>0.10</td></tr></table> |
bdb9f50e2fff631f9175846485a68fa0e5bdbac5824097cc090243ccca2426ec.png | simple | <table><tr><td>Active ROM Excursion</td><td>Dominant arm</td><td>Non Dominant arm</td><td> </td></tr><tr><td> </td><td>MSD</td><td>MSD</td><td>P-value</td></tr><tr><td>CAD (cm)</td><td>25.38 ± 3.67</td><td>24.70 ± 3.56</td><td><0.001*</td></tr><tr><td>FLX (°)</td><td>165.56 ± 7.76</td><td>164.52 ... | <table><tr><td>Active ROM Excursion</td><td>Dominant arm</td><td>Non Dominant arm</td><td></td></tr><tr><td></td><td>MSD</td><td>MSD</td><td>P-value</td></tr><tr><td>CAD (cm)</td><td>25.38 ± 3.67</td><td>24.70 ± 3.56</td><td><0.001*</td></tr><tr><td>FLX (°)</td><td>165.56 ± 7.76</td><td>164.52 ± 9.33</td><td><0.001*</t... | <table><tr><td>FLX (°)</td><td>170.55 ± 7.68</td><td>169.79 ± 9.44</td><td>0.009*</td></tr><tr><td>ER0 (°)</td><td>82.28 ± 12.34</td><td>80.48 ± 11.73</td><td><0.001*</td></tr><tr><td>IR 90° Abduction (°)</td><td>58.91 ± 14.04</td><td>62.43 ± 12.80</td><td><0.001*</td></tr><tr><td>ER 90° Abduction (°)</td><td>104.64 ± ... |
c95fd35f00e0b5ced7f2f7cb5f788a6da44f7fe5f266969fb80faf6c5361e0e7.png | complex | <table><tr><td>PFAS <i>n </i>= 1,566</td><td>Men (<i>n </i>= 956) β (95% CI)</td><td>All women (<i>n </i>= 958) β (95% CI)</td><td>Premenopausal women (<i>n </i>= 590) β (95% CI)</td><td>Postmenopausal women (<i>n </i>= 368) β (95% CI)</td></tr><tr><td>PFOA</td></tr><tr><td>Q1</td><td>Referent</td><... | <table><tr><td>PFAS n = 1,566</td><td>Men (n = 956) β (95% CI)</td><td>All women (n = 958) β (95% CI)</td><td>Premenopausal women (n = 590) β (95% CI)</td><td>Postmenopausal women (n = 368) β (95% CI)</td></tr><tr><td>PFOA</td><td colspan="4"></td></tr><tr><td>Q1</td><td>Referent</td><td>Referent</td><td>Referent</td><... | <table><tr><td>S</td><td>, –0.002)</td><td>–0.029, –0.002)</td><td>.015)</td><td>.049, –0.017)</td></tr><tr><td>PFHxS</td><td colspan="4"></td></tr><tr><td>Q1</td><td>Referent</td><td>Referent</td><td>Referent</td><td>Referent</td></tr><tr><td>Q2</td><td>–0.002 (–0.042, 0.038)</td><td>–0.008 (–0.039, 0.023)</td><td>–0.... |
17a086cd0b0a74148c4cbf14918564ec30f86b2b0646b1c4366399a680ccca46.png | complex | <table><tr><td></td><td colspan="3">Smoking status</td><td colspan="3">GOLD stage</td><td colspan="3">H. influenzae</td></tr><tr><td></td><td>Current smoker n = 15</td><td>Ex-smoker n = 29</td><td>p*</td><td>II n = 15</td><td>III+IV n = 29</td><td>p*</td><td>No n-12</td><td>Yes = n = 12</td><td>p*</td></tr><tr><td><i>I... | <table><tr><td></td><td colspan="3">Smoking status</td><td colspan="3">GOLD stage</td><td>H. influenzae</td></tr><tr><td></td><td>Current smoker n = 15</td><td>Ex-smoker n = 29</td><td>p*</td><td>II n = 15</td><td>III+IV n = 29</td><td>p*</td><td>No n-12</td></tr><tr><td>IL-6(pg/ml)</td><td></td><td></td><td></td><td><... | <table><tr><td colspan="2">H. influenzae</td></tr><tr><td>Yes = n = 12</td><td>p*</td></tr><tr><td></td><td></td></tr><tr><td>17.8(1.3-28.6)</td><td>0.16</td></tr><tr><td>12.0(2.6-18.8)</td><td>0.01</td></tr><tr><td></td><td></td></tr><tr><td>655.49(274.70-832.70)</td><td>0.32</td></tr><tr><td>570.4(265.8-1141.4)</td><... |
115d3e6d8fa12cf5d954cdae9e713f4f5e2aaa7486cc7b93d830013c784a2b58.png | simple | <table><tr><td>Hemodynamic variable</td><td>T0</td><td>T1</td><td>T2</td><td>p value</td></tr><tr><td>HR, beats.min<sup>−1</sup></td><td>96 (72,5 to 105.5)</td><td>93 (71.5 to 103.5)</td><td>91.5 (72.5 to 102.5)</td><td>0.067</td></tr><tr><td>PAM, mmHg</td><td>76.5 (71 to 83,6)</td><td>85 (76 to 90.5)<sup>a,b</su... | <table><tr><td>Hemodynamic variable</td><td>T0</td><td>T1</td><td>T2</td><td>p value</td></tr><tr><td>HR, beats.min−1</td><td>96 (72,5 to 105.5)</td><td>93 (71.5 to 103.5)</td><td>91.5 (72.5 to 102.5)</td><td>0.067</td></tr></table> | <table><tr><td>Hemodynamic variable</td><td>T0</td><td>T1</td><td>T2</td><td>p value</td></tr><tr><td>PAM, mmHg</td><td>76.5 (71 to 83,6)</td><td>85 (76 to 90.5)a,b</td><td>81 (72.5 to 92)</td><td><0.001*</td></tr><tr><td>PAPm, mmHg</td><td>25 (21 to 27)</td><td>28 (26 to 30)a,b</td><td>26 (24 to 29)c</td><td><0.001*</... |
b35996e6734601a9dc9e133e835c06429c0bcf7b2d26835493dab5ca939e1ced.png | simple | <table><tr><td>Strategy</td><td>Life time Cost $</td><td>Life time incremental cost$</td><td>Life years gain</td><td>Incremental life years gain</td><td>Cost effectiveness ($)</td><td>Incremental Cost Effectiveness ratio (ICER $)</td><td>% change from base case ICER</td></tr><tr><td><i>Undiscounted</i></td><td></td><td... | <table><tr><td>Strategy</td></tr><tr><td>Undiscounted</td></tr><tr><td>no-ART</td></tr><tr><td>ART</td></tr><tr><td>Discounted at 3%</td></tr><tr><td>no-ART</td></tr><tr><td>ART</td></tr></table> | <table><tr><td>Life time Cost $</td><td>Life time incremental cost$</td><td>Life years gain</td><td>Incremental life years gain</td><td>Cost effectiveness ($)</td><td>Incremental Cost Effectiveness ratio (ICER $)</td><td>% change from base case ICER</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td... |
f93da99ad7e66dfc2e7a417f82d11fc7d95872f6b1b07729de210f9a6f01973e.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">eGFR</td><td colspan="2">Urinary protein</td><td colspan="2">Systolic blood pressure</td></tr><tr><td>B*</td><td><i>p</i> value</td><td>B*</td><td><i>p</i> value</td><td>B*</td><td><i>p</i> value</td></tr><tr><td colspan="7"><i>Complement system components</i></td></tr><t... | <table><tr><td rowspan="2"></td><td colspan="2">eGFR</td><td colspan="2">Urinary protein</td><td colspan="2">Systolic blood pressure</td></tr><tr><td>B*</td><td>p value</td><td>B*</td><td>p value</td><td>B*</td><td>p value</td></tr><tr><td colspan="7">Complement system components</td></tr><tr><td>Complement C1q subcomp... | <table><tr><td>onent</td><td></td><td>05</td><td>+</td><td>7</td><td></td><td>03</td></tr><tr><td>Complement C3</td><td>−</td><td>0.3</td><td>−</td><td>0.5</td><td>+</td><td>0.2</td></tr><tr><td>Complement C4-B</td><td>−</td><td>0.2</td><td>+</td><td>0.9</td><td>+</td><td>0.05</td></tr><tr><td>Complement C5</td><td>−</... |
b273f692e0720e8688fed0c54de4c556cf400d4864bfec3ab2d19502861d1a8a.png | complex | <table><tr><td></td><td>Total number of isolates N = 973</td><td>Proportion of T2 isolates n (%)</td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariable analysis</td></tr><tr><td>Zone</td><td></td><td></td><td>**OR (95% CI)</td><td>p-value</td><td>OR (95% CI)</td><td>*p-value</td></tr><tr><td>South We... | <table><tr><td></td><td>Total number of isolates N = 973</td><td>Proportion of T2 isolates n (%)</td><td>Univariate analysis</td></tr><tr><td>Zone</td><td></td><td></td><td>**OR (95% CI)</td></tr><tr><td>South West</td><td>313</td><td>172 (55.0)</td><td>Ref.</td></tr><tr><td>Kampala</td><td>278</td><td>112 (40.3)</td><... | <table><tr><td>Univariate analysis</td><td colspan="2">Multivariable analysis</td></tr><tr><td>p-value</td><td>OR (95% CI)</td><td>*p-value</td></tr><tr><td></td><td>Ref.</td><td></td></tr><tr><td>0.004</td><td>1.8 (1.23-2.53)</td><td>0.005</td></tr><tr><td>1.57</td><td>1.9 (0.8-4.43)</td><td>0.122</td></tr><tr><td>0.0... |
38cffea20ddf92e1d9d16b10ee22a68f59c26dd708ed203e76dda7d1af25441d.png | complex | <table><tr><td rowspan="2">Phase</td><td colspan="2">Normothermia</td><td colspan="2">Hypothermia</td><td colspan="2">Mortality</td></tr><tr><td>Male</td><td>Female</td><td>Male</td><td>Female</td><td>Total</td><td><i>n</i></td></tr><tr><td>1</td><td>23</td><td>20</td><td></td><td></td><td>7 (14%)</td><td>43</td></tr><... | <table><tr><td rowspan="2">Phase</td><td colspan="2">Normothermia</td><td colspan="2">Hypothermia</td><td colspan="2">Mortality</td></tr><tr><td>Male</td><td>Female</td><td>Male</td><td>Female</td><td>Total</td><td>n</td></tr><tr><td>1</td><td>23</td><td>20</td><td></td><td></td><td>7 (14%)</td><td>43</td></tr><tr><td>... | <table><tr><td rowspan="2">Phase</td><td colspan="2">Normothermia</td><td colspan="2">Hypothermia</td><td colspan="2">Mortality</td></tr><tr><td>Male</td><td>Female</td><td>Male</td><td>Female</td><td>Total</td><td>n</td></tr><tr><td>3</td><td>3</td><td>4</td><td>3</td><td>5</td><td>1 (6.25%)</td><td>15</td></tr></tabl... |
b0c075871bae4bc471c881eecec3bcabe08374796de333c4cc999598b79d295e.png | complex | <table><tr><td></td><td colspan="3">Skewed Distributions</td><td colspan="3">Approximately Symmetric Distributions</td></tr><tr><td>Number of Factors</td><td>1</td><td>2</td><td>3</td><td>1</td><td>2</td><td>3</td></tr><tr><td>China</td><td>993</td><td>7</td><td>0</td><td>0</td><td>1000</td><td>0</td></tr><tr><td>India... | <table><tr><td></td><td colspan="3">Skewed Distributions</td><td colspan="3">Approximately Symmetric Distributions</td></tr></table> | <table><tr><td>Number of Factors</td><td>1</td><td>2</td><td>3</td><td>1</td><td>2</td><td>3</td></tr><tr><td>China</td><td>993</td><td>7</td><td>0</td><td>0</td><td>1000</td><td>0</td></tr><tr><td>India</td><td>62</td><td>938</td><td>0</td><td>0</td><td>932</td><td>18</td></tr><tr><td>Mexico</td><td>894</td><td>106</t... |
0bd2e05c4bc3a38993f4645bbb00ffe0555480053ae1e6e08e665beaf55a099e.png | simple | <table><tr><td>Property</td><td>Clarified Juice</td><td>UV Treatment</td></tr><tr><td>pH</td><td>3.74 ± 0.01 <sup>a</sup></td><td>3.54 ± 0.03 <sup>b</sup></td></tr><tr><td>Malic acid eq. (mg/mL)</td><td>6.19 ± 0.04 <sup>a</sup></td><td>6.06 ± 0.04 <sup>a</sup></td></tr><tr><td>°Brix</td><td>17.... | <table><tr><td>Property</td><td>Clarified Juice</td><td>UV Treatment</td></tr><tr><td>pH</td><td>3.74 ± 0.01 a</td><td>3.54 ± 0.03 b</td></tr><tr><td>Malic acid eq. (mg/mL)</td><td>6.19 ± 0.04 a</td><td>6.06 ± 0.04 a</td></tr><tr><td>°Brix</td><td>17.97 ± 0.06 a</td><td>18.05 ± 0.07 a</td></tr><tr><td>Ascorbic acid (pp... | <table><tr><td>Hue</td><td>81.37 ± 0.59 a</td><td>87.57 ± 0.51 b</td></tr><tr><td>Chroma</td><td>3.29 ± 1.21 a</td><td>5.10 ± 1.32 a</td></tr></table> |
33728b963aedca2d071dbc4c4c476f89014117ef596864212cdc6bf0a10f80ce.png | simple | <table><tr><td></td><td>Time Between Ultrasound and MRI</td><td>PC VIPR Pressure (mmHg)</td><td>Ultrasound Pressure (mmHg)</td><td>Stenosis (%)</td></tr><tr><td>No Repair</td><td>7 days</td><td>16.3</td><td>42**</td><td>32.8</td></tr><tr><td></td><td>5 months</td><td>32.3</td><td>33.8</td><td>26.2</td></tr><tr><td></td... | <table><tr><td></td><td>Time Between Ultrasound and MRI</td><td>PC VIPR Pressure (mmHg)</td><td>Ultrasound Pressure (mmHg)</td><td>Stenosis (%)</td></tr><tr><td>No Repair</td><td>7 days</td><td>16.3</td><td>42**</td><td>32.8</td></tr><tr><td></td><td>5 months</td><td>32.3</td><td>33.8</td><td>26.2</td></tr><tr><td></td... | <table><tr><td></td><td>Time Between Ultrasound and MRI</td><td>PC VIPR Pressure (mmHg)</td><td>Ultrasound Pressure (mmHg)</td><td>Stenosis (%)</td></tr><tr><td></td><td>2 years</td><td>-1.6</td><td>0*</td><td>24.8</td></tr></table> |
7ccc5187c5fd2dc65ac619656e8daea565ce4b99713bf11d38f1ceffa2704eb2.png | simple | <table><tr><td></td><td>Training set (n = 86)</td><td>Validation set (n = 42)</td></tr><tr><td>Error rate (%)</td><td>9.1</td><td>16.7</td></tr><tr><td>Sensitivity (%)</td><td>97.5</td><td>93.3</td></tr><tr><td>Specificity (%)</td><td>74.8</td><td>58.3</td></tr><tr><td>AUC</td><td>0.93</td><td>0.89</td></tr></table> | <table><tr><td></td><td>Training set (n = 86)</td><td>Validation set (n = 42)</td></tr><tr><td>Error rate (%)</td><td>9.1</td><td>16.7</td></tr><tr><td>Sensitivity (%)</td><td>97.5</td><td>93.3</td></tr></table> | <table><tr><td>Specificity (%)</td><td>74.8</td><td>58.3</td></tr><tr><td>AUC</td><td>0.93</td><td>0.89</td></tr></table> |
cd286a99134ba4b6172ce7e7a8f0e5fa0941668f3f2f5964932bc8adfd6e8125.png | complex | <table><tr><td>Name</td><td>Function</td><td>Primer Sequence (5' to 3')</td><td>Tm (°C)</td><td>Product Length</td><td>Amplified Region</td></tr><tr><td rowspan="2">SIRT2</td><td rowspan="2">RT-PCR</td><td>CAACCTGGAGAAATACCGTCTT</td><td rowspan="2">61.0</td><td rowspan="2">166 bp</td><td rowspan="2">400–565<... | <table><tr><td>Name</td><td>Function</td><td>Primer Sequence (5' to 3')</td><td>Tm (°C)</td><td>Product Length</td><td>Amplified Region</td></tr><tr><td rowspan="2">SIRT2</td><td rowspan="2">RT-PCR</td><td>CAACCTGGAGAAATACCGTCTT</td><td rowspan="2">61.0</td><td rowspan="2">166 bp</td><td rowspan="2">400–565</td></tr><t... | <table><tr><td>Name</td><td>Function</td><td>Primer Sequence (5' to 3')</td><td>Tm (°C)</td><td>Product Length</td><td>Amplified Region</td></tr><tr><td rowspan="2">RPS9</td><td rowspan="2">Reference</td><td>CCTCGACCAAGAGCTGAAG</td><td rowspan="2">61.0</td><td rowspan="2">64 bp</td><td rowspan="2">128–191</td></tr><tr>... |
d613e0d8f1d15a30164412287f7bb5eed7ab61980d39ed4f4e404a29a32e1cec.png | simple | <table><tr><td>Data set name</td><td>Description</td></tr><tr><td>LIVER CANCER [46]</td><td>Microarrays: 181; Probes: 6,605; <i>K </i>= 2Samples and Class: 76 normal; 105 tumorConfiguration: (ngr = 8, ngc = 4, nsr = 27, nsc = 28)http://genome-www5.stanford.edu/cgi-bin/publication/viewPublication.pl?pub_no=107</td></tr>... | <table><tr><td>Data set name</td><td>Description</td></tr><tr><td>LIVER CANCER [46]</td><td>Microarrays: 181; Probes: 6,605; K = 2Samples and Class: 76 normal; 105 tumorConfiguration: (ngr = 8, ngc = 4, nsr = 27, nsc = 28)http://genome-www5.stanford.edu/cgi-bin/publication/viewPublication.pl?pub_no=107</td></tr><tr><td... | <table><tr><td>Data set name</td><td>Description</td></tr><tr><td>LUNG CANCER [50]</td><td>Microarrays: 60; Probes: 20,601; K = 5Samples and Class: 6 normal; 35 adenocarcinoma (AC); 11 squamous cell carcinoma (SCC); 4 large cell lung cancer (LCLC); 4 small cell lung cancer (SCLC)Configuration: (ngr = 8, ngc = 4, nsr = ... |
16c12aabdf27a1ac35acbeddf70f9798a996e9b800e0317f8febc5f3f64cbd51.png | complex | <table><tr><td rowspan="2">Clinical characteristics</td><td colspan="3">LINE-1 methylation ratio by age and sex-adjusted</td></tr><tr><td>B</td><td>95% CI</td><td><i>P</i></td></tr><tr><td>HbA1c (%)</td><td>0.043</td><td>0.034 to 0.052</td><td>< 0.001</td></tr><tr><td>FBG (mmol/l)</td><td>0.063</td><td>0.048 to 0.07... | <table><tr><td>Clinical characteristics</td><td colspan="3">LINE-1 methylation ratio by age and sex-adjusted</td></tr></table> | <table><tr><td>Clinical characteristics</td><td>B</td><td>95% CI</td><td>P</td></tr><tr><td>HbA1c (%)</td><td>0.043</td><td>0.034 to 0.052</td><td>< 0.001</td></tr><tr><td>FBG (mmol/l)</td><td>0.063</td><td>0.048 to 0.077</td><td>< 0.001</td></tr><tr><td>TC (mmol/L)</td><td>−0.016</td><td>−0.024 to −0.009</td><td>< 0.0... |
58587cca8cff0ee88dfbfc942999f16c1f96aaac4ca1f62afb8c3dcd3e672d68.png | simple | <table><tr><td> </td><td>Total(<i>n</i> = 1889)</td><td>Male</td><td>Female</td><td><i>P</i></td></tr><tr><td>WC ≥90 cm in men and ≥80 cm in women, <i>n</i> (%)</td><td>278 (14.7)</td><td>85 (11.2)</td><td>193 (17.1)</td><td><0.001</td></tr><tr><td>SBP ≥130 mm Hg or DBP ≥85 mm Hg or hypertens... | <table><tr><td></td><td>Total(n = 1889)</td><td>Male</td><td>Female</td></tr><tr><td>WC ≥90 cm in men and ≥80 cm in women, n (%)</td><td>278 (14.7)</td><td>85 (11.2)</td><td>193 (17.1)</td></tr><tr><td>SBP ≥130 mm Hg or DBP ≥85 mm Hg or hypertensive treatment, n (%)</td><td>1064 (56.3)</td><td>406 (53.4)</td><td>658 (5... | <table><tr><td>P</td></tr><tr><td><0.001</td></tr><tr><td><0.05</td></tr><tr><td><0.05</td></tr><tr><td>0.19</td></tr><tr><td><0.05</td></tr></table> |
577e9380158cf320b12bca7ccdbf50839bb44e4739ac3939970c3af484e35915.png | simple | <table><tr><td> </td><td>Ingenuity canonical pathways</td><td><i>p</i>-value</td><td>Ratio</td><td>Molecules</td></tr><tr><td>A</td><td>TREM1 signaling</td><td>2.71 × 10<sup>-11</sup></td><td>1.69 × 10<sup>-1</sup></td><td>IL8, CXCL3, ICAM1, CD40, GRB2, IL10, TLR8, CASP1, IL1B, FCGR2B, NFKB1, TNF</td></tr><tr... | <table><tr><td></td><td>Ingenuity canonical pathways</td><td>p-value</td><td>Ratio</td><td>Molecules</td></tr></table> | <table><tr><td>A</td><td>TREM1 signaling</td><td>2.71 × 10-11</td><td>1.69 × 10-1</td><td>IL8, CXCL3, ICAM1, CD40, GRB2, IL10, TLR8, CASP1, IL1B, FCGR2B, NFKB1, TNF</td></tr><tr><td></td><td>Hepatic fibrosis/hepatic stellate cell activation</td><td>8.32 × 10-11</td><td>1.10 × 10-1</td><td>CXCL3, IL8, IL4R, CCR5, ICAM1,... |
3b7f227d5dae335b6f40bcceb247634a9dedd073f6c968fb24e526260a237235.png | complex | <table><tr><td></td><td colspan="3">Univariable</td><td colspan="3">Multivariable</td></tr><tr><td></td><td>Odds ratio</td><td>Confidential interval</td><td><i>p</i> value</td><td>Odds ratio</td><td>Confidential interval</td><td><i>p</i> value</td></tr><tr><td>Age</td><td>0.98</td><td>0.95–1.03</td><td>0.63</td><... | <table><tr><td></td><td colspan="3">Univariable</td><td colspan="3">Multivariable</td></tr><tr><td></td><td>Odds ratio</td><td>Confidential interval</td><td>p value</td><td>Odds ratio</td><td>Confidential interval</td><td>p value</td></tr><tr><td>Age</td><td>0.98</td><td>0.95–1.03</td><td>0.63</td><td>1.02</td><td>0.96... | <table><tr><td>Initial rhythm (VF and pulseless VT/asystole and PEA)</td><td>1.47</td><td>0.51–4.22</td><td>0.46</td><td>1.42</td><td>0.32–6.27</td><td>0.64</td></tr><tr><td>Location(out/in)</td><td>1.17</td><td>0.42–3.26</td><td>0.64</td><td>10.0</td><td>1.35–75.0</td><td>0.01</td></tr><tr><td>CPR duration</td><td>1.0... |
4dca5de86ee0bea11d0aaf2a2acb9bc2acdd1d2c3989da417a521037fb64b9eb.png | complex | <table><tr><td rowspan="2">Parameter</td><td colspan="2">Total</td><td colspan="2">With ≥ 2-year complete follow-up</td></tr><tr><td>Female</td><td>Male</td><td>Female</td><td>Male</td></tr><tr><td>Number of patients </td><td>802</td><td>526</td><td>463</td><td>313</td></tr><tr><td>Number of knees</td><td>1069</t... | <table><tr><td rowspan="2">Parameter</td><td colspan="2">Total</td><td colspan="2">With ≥ 2-year complete follow-up</td></tr><tr><td>Female</td><td>Male</td><td>Female</td><td>Male</td></tr><tr><td>Number of patients</td><td>802</td><td>526</td><td>463</td><td>313</td></tr></table> | <table><tr><td>Number of knees</td><td>1069</td><td>716</td><td>574</td><td>397</td></tr><tr><td>Proportion right knees</td><td>51.7%</td><td>49.4%</td><td>51.4%</td><td>49.4%</td></tr><tr><td>Patient age, mean (range) years</td><td>71.9 (39–95)</td><td>70.9 (44–96)</td><td>73.3 (50–94)</td><td>71.6 (48–95)</td></tr><t... |
c1813d27d41782b9dd3ae7a0d246386744d4f636e4d97ffbd9d10381df922380.png | simple | <table><tr><td>Parameters</td><td>Negative control</td><td>Standardmisoprostol 100 <i>μ</i>g/kg</td><td>Test-ITDFME 125 mg/kg</td><td>Test-IITDFME250 mg/kg</td><td>Test-IIITDFME500 mg/kg</td></tr><tr><td>Catalase</td><td>2.89 ± 0.11 (0.27)</td><td>4.09 ± 0.18 (0.44)<sup>b</sup></td><td>3.86 ± 0.12 (... | <table><tr><td>Parameters</td><td>Negative control</td></tr><tr><td>Catalase</td><td>2.89 ± 0.11 (0.27)</td></tr><tr><td>Malondialdehyde</td><td>7.11 ± 0.30 (0.74)</td></tr><tr><td>Mucin content</td><td>0.52 ± 0.06 (0.15)</td></tr><tr><td>Nonprotein sulphhydryl concentration</td><td>2.31 ± 0.18 (0.45)</td></tr><tr><td>... | <table><tr><td>Standardmisoprostol 100 μg/kg</td><td>Test-ITDFME 125 mg/kg</td><td>Test-IITDFME250 mg/kg</td><td>Test-IIITDFME500 mg/kg</td></tr><tr><td>4.09 ± 0.18 (0.44)b</td><td>3.86 ± 0.12 (0.49)a</td><td>3.94 ± 0.20 (0.49)a</td><td>4.23 ± 0.38 (0.94)b</td></tr><tr><td>2.69 ± 0.23 (0.57)c</td><td>5.64 ± 0.29 (0.73)... |
4ee3e2d4fca0f3b40c55c128f45b250ae81a3431cb8aaa17c406aec1d087b553.png | complex | <table><tr><td rowspan="2">Time points</td><td colspan="3">Bowel movement frequency, mean ± SD, episodes per wk</td><td colspan="3">Stool consistency, mean ± SD, BSFS grade</td></tr><tr><td>PEG</td><td>PEG + PM</td><td><i>P</i></td><td>PEG</td><td>PEG + PM</td><td><i>P</i></td></tr><tr><td>Enrollment</td><td>... | <table><tr><td rowspan="2">Time points</td><td colspan="3">Bowel movement frequency, mean ± SD, episodes per wk</td><td colspan="3">Stool consistency, mean ± SD, BSFS grade</td></tr><tr><td>PEG</td><td>PEG + PM</td><td>P</td><td>PEG</td><td>PEG + PM</td><td>P</td></tr><tr><td>Enrollment</td><td>2.5 ± 1.1</td><td>2.3 ± ... | <table><tr><td>4-week follow-up visit</td><td></td><td> 1.2</td><td>59</td><td>± 0.5</td><td>0.6</td><td>0.267</td></tr><tr><td>8-week follow-up visit</td><td>6.3 ± 0.9</td><td>6.3 ± 1.0</td><td>0.924</td><td>4.2 ± 0.5</td><td>4.2 ± 0.5</td><td>0.857</td></tr></table> |
9a57dfa7af9291d491ed2f26b15e80c7a382dc3f96c9ad42450431f307d3228c.png | complex | <table><tr><td rowspan="2">Variants</td><td rowspan="2">AA change</td><td rowspan="2">Novel</td><td rowspan="2">Exon</td><td colspan="2">Sift Prediction</td><td colspan="2">Polyphen Prediction</td><td colspan="3">MAF (%)</td></tr><tr><td>Score</td><td>Prediction</td><td>Score</td><td>Prediction</td><td>Control</td><td>... | <table><tr><td rowspan="2">Variants</td><td rowspan="2">AA change</td><td rowspan="2">Novel</td><td rowspan="2">Exon</td><td colspan="2">Sift Prediction</td><td colspan="2">Polyphen Prediction</td><td colspan="3">MAF (%)</td></tr><tr><td>Score</td><td>Prediction</td><td>Score</td><td>Prediction</td><td>Control</td><td>... | <table><tr><td>+21029 C/G</td><td>323A > P</td><td>Yes</td><td>5</td><td>0.08</td><td>Tolerated</td><td>0.476</td><td>Possibly damaging</td><td>0.5</td><td>0</td><td>0</td></tr><tr><td>rs2296651</td><td>267S > F</td><td>No</td><td>4</td><td>0.31</td><td>Tolerated</td><td>0.88</td><td>Probably damaging</td><td>0.9</td><... |
a4186abaa92333bb2aceb1396dad498ef0e219a1320d5704984413bc2e77e5cd.png | simple | <table><tr><td>Original value</td><td>HNR-I</td><td>HNR-II</td><td>HNR-III</td><td>HNR-IV</td><td>HNR-V</td><td>HNR-VI</td><td>Total </td></tr><tr><td>1-10</td><td>O/13</td><td>15/30</td><td>20/27</td><td>0/1</td><td>11/11</td><td>15/20</td><td><underline>61/102</underline>*<sup>#</sup></td></tr><tr><td>10-20</td><td>O... | <table><tr><td>Original value</td><td>HNR-I</td><td>HNR-II</td><td>HNR-III</td><td>HNR-IV</td><td>HNR-V</td><td>HNR-VI</td><td>Total</td></tr></table> | <table><tr><td>1-10</td><td>O/13</td><td>15/30</td><td>20/27</td><td>0/1</td><td>11/11</td><td>15/20</td><td>61/102*#</td></tr><tr><td>10-20</td><td>O/21</td><td>1/41</td><td>5/21</td><td>0/21</td><td>0/3</td><td>0/0</td><td>6/107§</td></tr><tr><td>≥20</td><td>0/16</td><td>0/16</td><td>0/21</td><td>0/16</td><td>0/23</t... |
c8e6a81f63d606fead334323f1e0618f65ea455f8eb7fd8531cb62638e5abdf7.png | complex | <table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td colspan="2">ICGA</td><td>FA</td><td></td></tr><tr><td>No.</td><td>Age</td><td>Sex</td><td>R/L</td><td>Cell/Flare</td><td>SRD</td><td>Optic disc hyperemia</td><td>Fuzzy choroidal vessels</td><td>Hypofluorescent dark dots</td><td>Pinpoints Hype... | <table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td colspan="2">ICGA</td><td>FA</td><td></td></tr><tr><td>No.</td><td>Age</td><td>Sex</td><td>R/L</td><td>Cell/Flare</td><td>SRD</td><td>Optic disc hyperemia</td><td>Fuzzy choroidal vessels</td><td>Hypofluorescent dark dots</td><td>Pinpoints Hype... | <table><tr><td rowspan="2">5</td><td rowspan="2">57</td><td rowspan="2">F</td><td>R</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td rowspan="2">+</td></tr><tr><td>L</td><td>+</td><td>−</td><td>+</td><td>+</td><td>+</td><td>−</td></tr><tr><td>6</td><td>24</td><td>M</td><td>R</td><td>−</td><td>+</td><... |
383f41dc38087c95b12dd75187a6cd0179d23067ae07e2fcdb9ad8e98566954e.png | complex | <table><tr><td>Supernatant</td><td>Colorimetric</td><td>HPLC</td><td>Difference</td></tr><tr><td>1</td><td>3.8</td><td>3.3</td><td>0.5</td></tr><tr><td>2</td><td>13</td><td>12.7</td><td>0.3</td></tr><tr><td>3</td><td>12.3</td><td>11.7</td><td>0.6</td></tr><tr><td>4</td><td>2.2</td><td>3</td><td>−0.8</td></tr><tr>... | <table><tr><td>Supernatant</td><td>Colorimetric</td></tr><tr><td>1</td><td>3.8</td></tr><tr><td>2</td><td>13</td></tr><tr><td>3</td><td>12.3</td></tr><tr><td>4</td><td>2.2</td></tr><tr><td>5</td><td>12.7</td></tr><tr><td>6</td><td>10.6</td></tr><tr><td>7</td><td>0.9</td></tr><tr><td>8</td><td>14.8</td></tr><tr><td>9</t... | <table><tr><td>HPLC</td><td>Difference</td></tr><tr><td>3.3</td><td>0.5</td></tr><tr><td>12.7</td><td>0.3</td></tr><tr><td>11.7</td><td>0.6</td></tr><tr><td>3</td><td>−0.8</td></tr><tr><td>13.7</td><td>−1.0</td></tr><tr><td>11.2</td><td>−0.6</td></tr><tr><td>1.1</td><td>−0.2</td></tr><tr><td>13.9</td><td>0.9</td></tr><... |
ec4ac7fd821387fe794b5d6cc9b3849f1388461daf26d3e6ec9d89c28f7c9edc.png | simple | <table><tr><td>Item NO.</td><td>PF</td><td>EF</td><td>SF</td><td>SchF</td></tr><tr><td>PF</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>QOL1</td><td>.42</td><td>.21</td><td>.30<sub>$</sub></td><td>.26</td></tr><tr><td>QOL2</td><td>.44</td><td>.18</td><td>.33<sub>$</sub></td><td>.28</td></tr><tr><td>QOL3</td>... | <table><tr><td>Item NO.</td><td>PF</td><td>EF</td><td>SF</td><td>SchF</td></tr><tr><td>PF</td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td>Item NO.</td><td>PF</td><td>EF</td><td>SF</td><td>SchF</td></tr><tr><td>QOL1</td><td>.42</td><td>.21</td><td>.30$</td><td>.26</td></tr><tr><td>QOL2</td><td>.44</td><td>.18</td><td>.33$</td><td>.28</td></tr><tr><td>QOL3</td><td>.53</td><td>.14</td><td>.26</td><td>.29</td></tr><tr><td>QOL4</td><td>.39</td>... |
ac4254f575574f6ff2861603281e30c27c00b44fe78d979944093c923b37abd7.png | complex | <table><tr><td>Potential operon (r value)</td><td>Gene ID</td><td>Putative or predicted function</td><td>Reference (s)</td></tr><tr><td colspan="4">Iron uptake or heme synthesis</td></tr><tr><td> <i>yfeABCD </i>operon* (r > 0.91)</td><td>YPO2439-2442</td><td>Transport/binding chelated iron</td><td><i>yfeABCD </i>[54... | <table><tr><td>Potential operon (r value)</td><td>Gene ID</td><td>Putative or predicted function</td><td>Reference (s)</td></tr><tr><td colspan="4">Iron uptake or heme synthesis</td></tr><tr><td>yfeABCD operon* (r > 0.91)</td><td>YPO2439-2442</td><td>Transport/binding chelated iron</td><td>yfeABCD [54]</td></tr><tr><td... | <table><tr><td>Potential operon (r value)</td><td>Gene ID</td><td>Putative or predicted function</td><td>Reference (s)</td></tr><tr><td>tauABCD operon (r > 0.90)</td><td>YPO0182-0185</td><td>Transport/binding taurine</td><td>tauABCD [56]</td></tr><tr><td>ssuEADCB operon (r > 0.97)</td><td>YPO3623-3627</td><td>Sulphur m... |
25f1b3fe4172c4ba1544c49f5778635bbe20de20b8a355b96ee20c57a4e59167.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="3">Male</td><td colspan="3">Female</td><td colspan="3">Overall</td></tr><tr><td>% active</td><td>95% CI</td><td><i>p</i> value</td><td>% active</td><td>95% CI</td><td><i>p</i> value</td><td>% active</td><td>95% CI</td><td><i>p</i> value</td></tr><tr><td colspan="10">... | <table><tr><td rowspan="2">Variable</td><td colspan="3">Male</td><td colspan="3">Female</td><td colspan="3">Overall</td></tr><tr><td>% active</td><td>95% CI</td><td>p value</td><td>% active</td><td>95% CI</td><td>p value</td><td>% active</td><td>95% CI</td><td>p value</td></tr></table> | <table><tr><td colspan="10">Age (years)</td></tr><tr><td>18–20</td><td>23.1</td><td>16.3–31.2</td><td rowspan="2">.24a</td><td>5.5</td><td>2.2–10.9</td><td rowspan="2">.65a</td><td>14.5</td><td>10.5–19.4</td><td rowspan="2">.11a</td></tr><tr><td>21–24</td><td>29.5</td><td>22.5–36.3</td><td>6.8</td><td>3.2–12.5</td><td>... |
bc95c74aa0972f623bffac32339f2792315260b0d652956aba95389371028aae.png | complex | <table><tr><td rowspan="3">Age Group</td><td rowspan="3"></td><td colspan="4">Boys</td><td colspan="4">Girls</td></tr><tr><td colspan="4">WC/Ht percentile</td><td colspan="4">WC/Ht percentile</td></tr><tr><td colspan="2">< 97th</td><td colspan="2">97-100th</td><td colspan="2">< 97th</td><td colspan="2">97-100th</... | <table><tr><td rowspan="2">Age Group</td><td rowspan="2"></td><td colspan="4">Boys</td><td colspan="4">Girls</td></tr><tr><td colspan="4">WC/Ht percentile</td><td colspan="4">WC/Ht percentile</td></tr></table> | <table><tr><td>Age Group</td><td></td><td colspan="2">< 97th</td><td colspan="2">97-100th</td><td colspan="2">< 97th</td><td colspan="2">97-100th</td></tr><tr><td rowspan="7">6-9 yr</td><td>n</td><td colspan="2">40</td><td colspan="2">154</td><td colspan="2">14</td><td colspan="2">142</td></tr><tr><td>Systolic BP < 130... |
d064b8ebac6090fe4a2199e6f52b23079cc781ef277f2c55c2b9e8ad8a51b771.png | simple | <table><tr><td> </td><td>Actual positive</td><td>Actual negative</td></tr><tr><td>Predicted positive</td><td>TP</td><td>FP</td></tr><tr><td>Predicted negative</td><td>FN</td><td>TN</td></tr></table> | <table><tr><td></td><td>Actual positive</td><td>Actual negative</td></tr></table> | <table><tr><td>Predicted positive</td><td>TP</td><td>FP</td></tr><tr><td>Predicted negative</td><td>FN</td><td>TN</td></tr></table> |
3a590148a950f60161672739f46a2519ded17cbfa435ba5a163a529d685acf00.png | simple | <table><tr><td></td><td>NS</td><td>HA</td><td>RD</td><td>P</td><td></td></tr><tr><td>NS</td><td>–</td><td>−0.431<sup>**</sup></td><td>0.207<sup>*</sup></td><td>−0.128</td><td></td></tr><tr><td>HA</td><td>−0.431<sup>**</sup></td><td>–</td><td>0.009</td><td>−0.165</td><td></td></tr><tr... | <table><tr><td></td><td>NS</td><td>HA</td><td>RD</td><td>P</td><td></td></tr><tr><td>NS</td><td>–</td><td>−0.431**</td><td>0.207*</td><td>−0.128</td><td></td></tr><tr><td>HA</td><td>−0.431**</td><td>–</td><td>0.009</td><td>−0.165</td><td></td></tr><tr><td>RD</td><td>0.207*</td><td>0.009</td><td>–</td><td>−0.088</td><td... | <table><tr><td>P</td><td>−0.128</td><td>−0.165</td><td>−0.088</td><td>–</td><td></td></tr><tr><td></td><td>NS</td><td>NS1</td><td>NS2</td><td>NS3</td><td>NS4</td></tr><tr><td>NS</td><td>–</td><td>0.551**</td><td>0.652**</td><td>0.715**</td><td>0.640**</td></tr><tr><td>NS1</td><td>0.551**</td><td>–</td><td>−0.006</td><t... |
6585f957735f4590cbf0920cc688245f7498e630d9adab52952e343cf149b873.png | simple | <table><tr><td>Clinical source</td><td>Total strains</td><td>ZOT positivity</td><td>Exotoxin 9 positivity</td><td>GSI</td><td>GSII</td></tr><tr><td>CD</td><td>29</td><td>72.41</td><td>72.41</td><td>10.34</td><td>89.66</td></tr><tr><td>Gastroenteritis</td><td>31</td><td>70.97</td><td>51.61</td><td>35.48</td><td>64.52</t... | <table><tr><td>Clinical source</td><td>Total strains</td><td>ZOT positivity</td><td>Exotoxin 9 positivity</td><td>GSI</td><td>GSII</td></tr><tr><td>CD</td><td>29</td><td>72.41</td><td>72.41</td><td>10.34</td><td>89.66</td></tr><tr><td>Gastroenteritis</td><td>31</td><td>70.97</td><td>51.61</td><td>35.48</td><td>64.52</t... | <table><tr><td>UC</td><td>4</td><td>25</td><td></td><td>0</td><td></td></tr><tr><td>All</td><td>88</td><td>71.59</td><td>60.22</td><td>28.41</td><td>71.59</td></tr></table> |
f4b16fa330f67deeb9b342bc6b9acc6dfb8dd143b86a64803ee32f81557adee8.png | simple | <table><tr><td>Anterior segment pathology</td><td>Number of eyes</td></tr><tr><td>Cornea diseases</td><td></td></tr><tr><td> Mucopolysaccharidosis</td><td>4</td></tr><tr><td> Keratoconus</td><td>3</td></tr><tr><td>Anterior segment congenital condition</td><td></td></tr><tr><td> Mesoectodermal dysgenesis</td><td>2</td><... | <table><tr><td>Anterior segment pathology</td><td>Number of eyes</td></tr><tr><td>Cornea diseases</td><td></td></tr><tr><td>Mucopolysaccharidosis</td><td>4</td></tr><tr><td>Keratoconus</td><td>3</td></tr><tr><td>Anterior segment congenital condition</td><td></td></tr><tr><td>Mesoectodermal dysgenesis</td><td>2</td></tr... | <table><tr><td>Anterior segment pathology</td><td>Number of eyes</td></tr><tr><td>Iridocorneal angle abnormalities</td><td></td></tr><tr><td>Anterior synechiae post-uveitis</td><td>1</td></tr><tr><td>Neovascular glaucoma</td><td>2</td></tr><tr><td>Synechia associated to ciliary body lesion</td><td>1</td></tr><tr><td>In... |
9ae441ea559c6bd739e66f4bbf28ab33b8864d642ad81849eab472617bdce229.png | complex | <table><tr><td> </td><td colspan="3">Discussed with an HIV nurse practitioner</td><td colspan="3">Discussed with an HIV care medical doctor</td><td colspan="3">Discussed at the HIV care visit</td></tr><tr><td> </td><td>Never</td><td>Sometimes</td><td>Regularly</td><td>Never</td><td>Sometimes</td><td>Regularly</td><td>N... | <table><tr><td></td><td colspan="3">Discussed with an HIV nurse practitioner</td><td colspan="3">Discussed with an HIV care medical doctor</td><td colspan="3">Discussed at the HIV care visit</td></tr><tr><td></td><td>Never</td><td>Sometimes</td><td>Regularly</td><td>Never</td><td>Sometimes</td><td>Regularly</td><td>Nev... | <table><tr><td></td><td colspan="3">Discussed with an HIV nurse practitioner</td><td colspan="3">Discussed with an HIV care medical doctor</td><td colspan="3">Discussed at the HIV care visit</td></tr><tr><td></td><td>Never</td><td>Sometimes</td><td>Regularly</td><td>Never</td><td>Sometimes</td><td>Regularly</td><td>Nev... |
8cbb3b2a292bbb4a10a21bf73e3eb12ca21117ee4ee868ddc3b37d08cffbc507.png | simple | <table><tr><td>Age</td><td>Discharge type</td><td>Single duct?</td><td>Initial surgery</td><td>Initial histology</td><td>Final histology</td><td>Treatment</td></tr><tr><td>32</td><td>Fresh blood</td><td>Yes</td><td>Micro</td><td>DCIS</td><td>Intermediate grade DCIS</td><td>Mx + ANS + recon</td></tr><tr><td>43</td><td>F... | <table><tr><td>Age</td><td>Discharge type</td><td>Single duct?</td></tr><tr><td>32</td><td>Fresh blood</td><td>Yes</td></tr><tr><td>43</td><td>Fresh blood</td><td>No</td></tr><tr><td>51</td><td>Fresh blood/serous</td><td>Yes</td></tr><tr><td>58</td><td>Fresh blood</td><td>Yes</td></tr><tr><td>60</td><td>Fresh blood</td... | <table><tr><td>Initial surgery</td><td>Initial histology</td><td>Final histology</td><td>Treatment</td></tr><tr><td>Micro</td><td>DCIS</td><td>Intermediate grade DCIS</td><td>Mx + ANS + recon</td></tr><tr><td>TDE</td><td>DCIS</td><td>Extensive intermediate grade DCIS</td><td>Mx + ANS + recon</td></tr><tr><td>TDE</td><t... |
62ae3ccb67cd1002016b86318600be3a568b42d2dfa9bd78dcdd0103aec687e8.png | complex | <table><tr><td rowspan="2"></td><td>Nonretreatment Group B</td><td>Retreatment Group A</td></tr><tr><td>(<i>N</i> = 106)</td><td>(<i>N</i> = 125)</td></tr><tr><td>Age, years</td><td></td><td></td></tr><tr><td> Mean (SD)</td><td>61.4 (10.00)</td><td>60.8 (10.39)</td></tr><tr><td>Gender, N (%)</td><td></td><td></td></tr>... | <table><tr><td rowspan="2"></td><td>Nonretreatment Group B</td><td>Retreatment Group A</td></tr><tr><td>(N = 106)</td><td>(N = 125)</td></tr><tr><td>Age, years</td><td></td><td></td></tr><tr><td>Mean (SD)</td><td>61.4 (10.00)</td><td>60.8 (10.39)</td></tr><tr><td>Gender, N (%)</td><td></td><td></td></tr><tr><td>Female<... | <table><tr><td>Grade 2</td><td>46 (43.4)</td><td>42 (33.6)</td></tr><tr><td>Grade 3</td><td>49 (46.2)</td><td>73 (58.4)</td></tr><tr><td>WOMAC pain subscores - Study Knee (mean)</td><td>68.1</td><td>69.0</td></tr></table> |
944e938b7676e91654602dd0c7fa67cf05a31330e949fd4d2e9fa6422ebae02d.png | simple | <table><tr><td>Subtype</td><td>OMIM ID</td><td>Causative gene</td><td>HGNC ID</td><td>Cytogenetic location</td><td>Inheritance</td></tr><tr><td>FHL1</td><td>267700</td><td><i>HPLH1</i><sup>a</sup></td><td>HGNC:23824</td><td>9q21.3 - q22</td><td>AR</td></tr><tr><td>FHL2</td><td>603553</td><td><i>PRF1</i></td><td>HGNC:93... | <table><tr><td>Subtype</td><td>OMIM ID</td><td>Causative gene</td><td>HGNC ID</td><td>Cytogenetic location</td><td>Inheritance</td></tr><tr><td>FHL1</td><td>267700</td><td>HPLH1a</td><td>HGNC:23824</td><td>9q21.3 - q22</td><td>AR</td></tr></table> | <table><tr><td>Subtype</td><td>OMIM ID</td><td>Causative gene</td><td>HGNC ID</td><td>Cytogenetic location</td><td>Inheritance</td></tr><tr><td>FHL2</td><td>603553</td><td>PRF1</td><td>HGNC:9360</td><td>10q22.1</td><td>AR</td></tr><tr><td>FHL3</td><td>608898</td><td>UNC13D</td><td>HGNC:23147</td><td>17q25.1</td><td>AR ... |
d10941af0c88f64d6de05460182801b978b64f2d2f32c7bc062f1db989f5cdf6.png | simple | <table><tr><td>Clinical symptoms</td><td>PCNSL(NO of patients)</td><td>GBM(NO of patients)</td></tr><tr><td>Organic brain syndrome</td><td>22</td><td>12</td></tr><tr><td>Signs of intracranial hypertension</td><td>16</td><td>23</td></tr><tr><td>Paresis</td><td>16</td><td>19</td></tr><tr><td>Vertigo</td><td>12</td><td>13... | <table><tr><td>Clinical symptoms</td><td>PCNSL(NO of patients)</td><td>GBM(NO of patients)</td></tr><tr><td>Organic brain syndrome</td><td>22</td><td>12</td></tr><tr><td>Signs of intracranial hypertension</td><td>16</td><td>23</td></tr></table> | <table><tr><td>Paresis</td><td>16</td><td>19</td></tr><tr><td>Vertigo</td><td>12</td><td>13</td></tr><tr><td>Phatic disorder</td><td>11</td><td>14</td></tr><tr><td>Visual disturbances</td><td>7</td><td>3</td></tr><tr><td>Cranial nerve dysfunction other than visual disturbance</td><td>5</td><td>0</td></tr><tr><td>Fatigu... |
82c61fbc461655d4f7708fb66783368ac2c5e3fddc390ce0eb6a0a86bee01adc.png | simple | <table><tr><td>Description</td><td>Unit</td><td><i>n</i></td><td>Abbreviation</td></tr><tr><td>Milk yield</td><td>l/day</td><td>285</td><td>dMY</td></tr><tr><td>FMI per visit</td><td>kg/visit</td><td>13,908</td><td>vFMI</td></tr><tr><td>Feeding duration per visit</td><td>s/visit</td><td>13,908</td><td>vFdur</td></tr><t... | <table><tr><td>Description</td><td>Unit</td></tr><tr><td>Milk yield</td><td>l/day</td></tr><tr><td>FMI per visit</td><td>kg/visit</td></tr><tr><td>Feeding duration per visit</td><td>s/visit</td></tr><tr><td>FMI (fresh matter intake)</td><td>kg/day</td></tr><tr><td>Feeding time</td><td>min/day</td></tr><tr><td>Feeding f... | <table><tr><td>n</td><td>Abbreviation</td></tr><tr><td>285</td><td>dMY</td></tr><tr><td>13,908</td><td>vFMI</td></tr><tr><td>13,908</td><td>vFdur</td></tr><tr><td>311</td><td>dFMI</td></tr><tr><td>311</td><td>dFtime</td></tr><tr><td>311</td><td>dFfreq</td></tr><tr><td>311</td><td>mvFMI</td></tr><tr><td>311</td><td>mvFd... |
0c99219a0278a94fc66af7dbdbb229212ff5dcd1827932d034712ca1656740d1.png | simple | <table><tr><td>Characteristics<sup>a</sup></td><td>Cases(n = 1760)</td><td>Controls(n = 2481)</td></tr><tr><td></td><td>No. (%)</td><td>No. (%)</td></tr><tr><td>Age (years)*</td><td></td><td></td></tr><tr><td> 18-49</td><td>368(20.9)</td><td>265(10.7)</td></tr><tr><td> 50-59</td><td>412(23.4)</td><td>690(27.8)</td></tr... | <table><tr><td>Characteristicsa</td><td>Cases(n = 1760)</td><td>Controls(n = 2481)</td></tr><tr><td></td><td>No. (%)</td><td>No. (%)</td></tr><tr><td>Age (years)*</td><td></td><td></td></tr><tr><td>18-49</td><td>368(20.9)</td><td>265(10.7)</td></tr><tr><td>50-59</td><td>412(23.4)</td><td>690(27.8)</td></tr><tr><td>60-6... | <table><tr><td>derweight(< 18.5)</td><td>23(1.3)</td><td>0.9)</td></tr><tr><td>Normal(18.5-24.9)</td><td>595(33.8)</td><td>930(37.5)</td></tr><tr><td>Overweight (25-29.9)</td><td>748(42.5)</td><td>1069(43.1)</td></tr><tr><td>Obese(≥ 30)</td><td>394(22.4)</td><td>460(18.5)</td></tr><tr><td>Physical activity (METs/weekb)... |
7565271b28fe601432830e841eb4fb3624d4010f4387d9da5af41159756c4139.png | simple | <table><tr><td>Downregulated Pathways</td><td>Fat</td><td>Liver</td><td>Muscle</td><td>Comments</td></tr><tr><td>Steroid Biosynthesis</td><td></td><td>Q; EQ</td><td></td><td>Target of Statins</td></tr><tr><td>Phagocytosis/ leukocyte extravasation</td><td>EQ</td><td></td><td></td><td>Innate Immune Response</td></tr><tr>... | <table><tr><td>Downregulated Pathways</td><td>Fat</td><td>Liver</td><td>Muscle</td><td>Comments</td></tr><tr><td>Steroid Biosynthesis</td><td></td><td>Q; EQ</td><td></td><td>Target of Statins</td></tr><tr><td>Phagocytosis/ leukocyte extravasation</td><td>EQ</td><td></td><td></td><td>Innate Immune Response</td></tr><tr>... | <table><tr><td>Downregulated Pathways</td><td>Fat</td><td>Liver</td><td>Muscle</td><td>Comments</td></tr><tr><td>eIF4/p70S6K signaling</td><td></td><td></td><td>Q; EQ</td><td>Insulin Signaling</td></tr><tr><td>Oxidative phosphorylation</td><td></td><td></td><td>Q; EQ</td><td>Energy Production</td></tr><tr><td>PPARα/RXR... |
91ae8123e07455f33365b36497346b24380438c9bfdc154d60237bfee1473fbd.png | complex | <table><tr><td></td><td colspan="3">Termamyl</td></tr><tr><td>Parameter</td><td>Model (5) versus model (1)</td><td>Model (6) versus model (1)</td><td>Model (7) versus model (1)</td></tr><tr><td rowspan="3"><i>v</i><sub>max⁡</sub></td><td><i>t</i> value = −2.874</td><td><i>t</i> value = −3.214</td><td>... | <table><tr><td></td><td colspan="3">Termamyl</td></tr><tr><td>Parameter</td><td>Model (5) versus model (1)</td><td>Model (6) versus model (1)</td><td>Model (7) versus model (1)</td></tr><tr><td rowspan="3">vmax</td><td>t value = −2.874</td><td>t value = −3.214</td><td>t value = −3.327</td></tr><tr><td>P value = 0.045*... | <table><tr><td>vmax</td><td>D.F. = 4</td><td>D.F. = 4</td><td>D.F. = 4</td></tr><tr><td rowspan="3">KM</td><td>t value = −1.982</td><td>t value = −1.895</td><td>t value = −1.778</td></tr><tr><td>P value = 0.118</td><td>P value = 0.131</td><td>P value = 0.150</td></tr><tr><td>D.F. = 4</td><td>D.F. = 4</td><td>D.F. = 4<... |
a32eeea8f47597dbac240a5049bc56235803cf58d1f063e75fa91b825d7f6c82.png | complex | <table><tr><td colspan="6">Health Care Providers</td></tr><tr><td rowspan="2">Unqualified providers (UQP)</td><td colspan="2">Yes</td><td rowspan="2">Qualified Providers (QP)</td><td colspan="2">Yes</td></tr><tr><td>n*</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Village doctor</td><td>416</td><td>92.7</td><td>Public... | <table><tr><td colspan="6">Health Care Providers</td></tr><tr><td rowspan="2">Unqualified providers (UQP)</td><td colspan="2">Yes</td><td rowspan="2">Qualified Providers (QP)</td><td colspan="2">Yes</td></tr><tr><td>n*</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Village doctor</td><td>416</td><td>92.7</td><td>Public... | <table><tr><td colspan="6">Health Care Providers</td></tr><tr><td rowspan="2">Unqualified providers (UQP)</td><td colspan="2">Yes</td><td rowspan="2">Qualified Providers (QP)</td><td colspan="2">Yes</td></tr><tr><td>n*</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Spiritual treatment</td><td>94</td><td>20.9</td><td></... |
44df6a53886dd442961e8cd3e4ea024d15236809a22688fb11b72af793c6013b.png | simple | <table><tr><td></td><td><i>No CAD (%) (n = 15)</i></td><td><i>CAD (%) (n = 38)</i></td></tr><tr><td>Hypertension (blood pressure > 140/90 mmHg or on antihypertensive therapy)</td><td>60</td><td>97</td></tr><tr><td>Increased abdominal circumference (male > 92 cm, females > 88 cm)</td><td>33.3</td><td>79.1</td><... | <table><tr><td></td><td>No CAD (%) (n = 15)</td><td>CAD (%) (n = 38)</td></tr><tr><td>Hypertension (blood pressure > 140/90 mmHg or on antihypertensive therapy)</td><td>60</td><td>97</td></tr><tr><td>Increased abdominal circumference (male > 92 cm, females > 88 cm)</td><td>33.3</td><td>79.1</td></tr><tr><td>Abnormal gl... | <table><tr><td></td><td>No CAD (%) (n = 15)</td><td>CAD (%) (n = 38)</td></tr><tr><td>Increased CIMT (> 0.8 mm)</td><td>53</td><td>76</td></tr></table> |
53e1bf6d8a2e02ded0e84c83d37a6486bee4ff385c40e239e2556974fa6211ac.png | complex | <table><tr><td>(<i>N</i> = 24)</td><td colspan="2"> Distance from the bladder neck</td><td>Distance from the echolucent urethral lumen</td></tr><tr><td> </td><td>[mm]</td><td>% of urethral length</td><td>[mm]</td></tr><tr><td>Mean</td><td>19.43</td><td>64.9%</td><td>3.13</td></tr><tr><td>Median</td><td>19.00</td><td>64... | <table><tr><td>(N = 24)</td><td colspan="2">Distance from the bladder neck</td><td>Distance from the echolucent urethral lumen</td></tr><tr><td></td><td>[mm]</td><td>% of urethral length</td><td>[mm]</td></tr></table> | <table><tr><td>Mean</td><td>19.43</td><td>64.9%</td><td>3.13</td></tr><tr><td>Median</td><td>19.00</td><td>64.5%</td><td>3.30</td></tr><tr><td>Std. dev.</td><td>3.19</td><td>6.9%</td><td>0.94</td></tr></table> |
acbbfca8df8d21024b1462b735c53f22cc5e1ae6db7d985b19f842a062be47b8.png | simple | <table><tr><td>Parameter</td><td>Control (n=56)</td><td>Oil refinery workers (n=56)</td><td>p-value</td></tr><tr><td>Age (years)</td><td>30.02±1.76</td><td>35.20±1.62</td><td>0.320</td></tr><tr><td>Height (cm)</td><td>174±0.93</td><td>170.75±0.83</td><td>0.100</td></tr><tr><td>Weight (kg)</td><td>80... | <table><tr><td>Parameter</td><td>Control (n=56)</td><td>Oil refinery workers (n=56)</td></tr><tr><td>Age (years)</td><td>30.02±1.76</td><td>35.20±1.62</td></tr><tr><td>Height (cm)</td><td>174±0.93</td><td>170.75±0.83</td></tr><tr><td>Weight (kg)</td><td>80.25±2.68</td><td>78.36±1.55</td></tr><tr><td>FVC (lit)</td><td>5... | <table><tr><td>p-value</td></tr><tr><td>0.320</td></tr><tr><td>0.100</td></tr><tr><td>0.543</td></tr><tr><td>0.083</td></tr><tr><td>0.0001</td></tr><tr><td>0.013</td></tr><tr><td>0.0001</td></tr><tr><td>0.0001</td></tr><tr><td>0.012</td></tr><tr><td>0.151</td></tr></table> |
59b32736ba638d38d6e1e02d8c14bd795822e922bcd1e92acc6ddd49b8a9e2cb.png | complex | <table><tr><td rowspan="3"></td><td colspan="7">Response options for doctors and researchers<sup>b</sup></td><td></td></tr><tr><td>Benefit</td><td></td><td></td><td></td><td>Harm</td><td></td><td></td><td></td></tr><tr><td>A great deal</td><td>Quite a lot</td><td>Only a little</td><td>No benefit or harm</td><td>Only a ... | <table><tr><td rowspan="3"></td><td colspan="7">Response options for doctors and researchersb</td><td></td></tr><tr><td>Benefit</td><td></td><td></td><td></td><td>Harm</td><td></td><td></td><td></td></tr><tr><td>A great deal</td><td>Quite a lot</td><td>Only a little</td><td>No benefit or harm</td><td>Only a little</td>... | <table><tr><td>ed or here was no progress in care</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>11. Suspicion of negative PREM or refusal of school doctor services in the future and no progress in care</td><td></td><td></td><td></td><td></td><td></td><td></td><td>x</td><td></t... |
113250e038d664ea1c3272628697f81e2dc7aa766491803a6c57ec4a1d97c8b5.png | simple | <table><tr><td>Source</td><td>A lot</td><td>A fair amount</td><td>A little</td><td>Almost none</td></tr><tr><td>Chicago City Health Department</td><td>9.5</td><td>21.4</td><td>33.3</td><td>35.7</td></tr><tr><td>Chicago Housing Authority</td><td>9.5</td><td>14.3</td><td>23.8</td><td>52.4</td></tr><tr><td>Doctor</td><td>... | <table><tr><td>Source</td><td>A lot</td><td>A fair amount</td><td>A little</td><td>Almost none</td></tr></table> | <table><tr><td>Chicago City Health Department</td><td>9.5</td><td>21.4</td><td>33.3</td><td>35.7</td></tr><tr><td>Chicago Housing Authority</td><td>9.5</td><td>14.3</td><td>23.8</td><td>52.4</td></tr><tr><td>Doctor</td><td>19.1</td><td>14.3</td><td>21.4</td><td>45.2</td></tr><tr><td>Friends and relatives</td><td>31.0</... |
5846c08439721d16b142aea8db951f6a2359c4a032a04e5f7ed4c17514b2c8e7.png | complex | <table><tr><td rowspan="2">Species</td><td colspan="3">Whole wing</td><td colspan="3">Red band</td></tr><tr><td><i>t</i></td><td><i>df</i></td><td><i>p</i></td><td><i>t</i></td><td><i>df</i></td><td><i>p</i></td></tr><tr><td><i>H. erato phyllis</i></td><td>0.46</td><td>57.18</td><td>.65</td><td>0.30</td><td>52.82</td><... | <table><tr><td rowspan="2">Species</td><td colspan="3">Whole wing</td><td colspan="3">Red band</td></tr><tr><td>t</td><td>df</td><td>p</td><td>t</td><td>df</td><td>p</td></tr><tr><td>H. erato phyllis</td><td>0.46</td><td>57.18</td><td>.65</td><td>0.30</td><td>52.82</td><td>.77</td></tr><tr><td>H. besckei</td><td>0.76</... | <table><tr><td rowspan="2">Species</td><td colspan="3">Whole wing</td><td colspan="3">Red band</td></tr><tr><td>t</td><td>df</td><td>p</td><td>t</td><td>df</td><td>p</td></tr><tr><td>H. melpomene nanna</td><td>0.39</td><td>48.31</td><td>.70</td><td>−3.22</td><td>50.28</td><td>.002a</td></tr></table> |
932c12f7b65c7f5b1350a435c89daa4631381fa2f9a3317cebf2275c29a436d5.png | simple | <table><tr><td>Appendix I: Key Economic Variables</td><td></td><td>Reference/Data Source</td></tr><tr><td>ECONOMIC</td><td></td><td></td></tr><tr><td>Annual Discount Rate</td><td>3%</td><td>27</td></tr><tr><td>Exchange Rate: Shekels to USD (2005)</td><td>4.35</td><td>12</td></tr><tr><td>Per capita GDP (USD 2003)</td><t... | <table><tr><td>Appendix I: Key Economic Variables</td><td></td></tr><tr><td>ECONOMIC</td><td></td></tr><tr><td>Annual Discount Rate</td><td>3%</td></tr><tr><td>Exchange Rate: Shekels to USD (2005)</td><td>4.35</td></tr><tr><td>Per capita GDP (USD 2003)</td><td>$16,497</td></tr><tr><td>Training Staff</td><td></td></tr><... | <table><tr><td>Reference/Data Source</td></tr><tr><td></td></tr><tr><td>27</td></tr><tr><td>12</td></tr><tr><td>12</td></tr><tr><td></td></tr><tr><td>MOH Statistical Dept.</td></tr><tr><td>Ashkelon Project</td></tr><tr><td>Ashkelon Project</td></tr><tr><td>Ashkelon Project</td></tr><tr><td>Ashkelon Project</td></tr><tr... |
8e3f39f15fed47271ed821b537bd2a65cbef1633786a377542b37f67f8985b61.png | simple | <table><tr><td>First author (public year) [Reference]</td><td>Experimental animal</td><td>Inoculum spores</td><td>Inoculation route</td><td>Outcome</td><td>Results</td></tr><tr><td>Kawai (2012) [2]</td><td>4-5-d old ddY mouse</td><td><i>Kudoa septempunctata</i></td><td>Oral</td><td>Bowel movements and FAR</td><td>Showi... | <table><tr><td>First author (public year) [Reference]</td><td>Experimental animal</td><td>Inoculum spores</td><td>Inoculation route</td><td>Outcome</td><td>Results</td></tr><tr><td>Kawai (2012) [2]</td><td>4-5-d old ddY mouse</td><td>Kudoa septempunctata</td><td>Oral</td><td>Bowel movements and FAR</td><td>Showing diar... | <table><tr><td>First author (public year) [Reference]</td><td>Experimental animal</td><td>Inoculum spores</td><td>Inoculation route</td><td>Outcome</td><td>Results</td></tr><tr><td>hn (2015) [6]</td><td>/c mice</td><td>udoa septempunc-tata</td><td>al</td><td>-pathological examination</td><td>rhea (0/32) and histopathol... |
35424e6e53323314721d3938419ad2c941765a517aa51acfbaa99c4f89609abd.png | complex | <table><tr><td> </td><td colspan="2">AMR</td><td colspan="2">AMR + PLR</td><td colspan="2">Total</td></tr><tr><td>Stage</td><td>Age (SD)/No.</td><td>F/M (Ratio)</td><td>Age (SD)/No.</td><td>F/M (Ratio)</td><td>Age (SD)/No.</td><td>F/M (Ratio)</td></tr><tr><td>I</td><td>52 (9)/37</td><td>30/7 (4.3)</td><td>55 (10)/12</t... | <table><tr><td></td><td colspan="2">AMR</td><td colspan="2">AMR + PLR</td><td colspan="2">Total</td></tr><tr><td>Stage</td><td>Age (SD)/No.</td><td>F/M (Ratio)</td><td>Age (SD)/No.</td><td>F/M (Ratio)</td><td>Age (SD)/No.</td><td>F/M (Ratio)</td></tr><tr><td>I</td><td>52 (9)/37</td><td>30/7 (4.3)</td><td>55 (10)/12</td... | <table><tr><td></td><td colspan="2">AMR</td><td colspan="2">AMR + PLR</td><td colspan="2">Total</td></tr><tr><td>III</td><td>64 (8)/170</td><td>147/23 (6.4)</td><td>63 (5)/37</td><td>32/5 (6.4)</td><td>64 (7)/207</td><td>179/28 (4.6)</td></tr><tr><td>IV</td><td>62 (7)/36</td><td>30/6 (5.0)</td><td>66 (1)/3</td><td>3/0 ... |
5640f1ef6a4c1d4d9836b9443c0aa61e7a7423999ec9615001ff7de16a75725f.png | simple | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td></tr><tr><td>MIGS-31</td><td>Finishing quality</td><td>High quality draft</td></tr><tr><td>MIGS-28</td><td>Libraries used</td><td>IonTorrent 100 bp and 400 bp single end reads</td></tr><tr><td>MIGS-29</td><td>Sequencing platforms</td><td>IonTorrent PGM</td></tr><... | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td></tr><tr><td>MIGS-31</td><td>Finishing quality</td><td>High quality draft</td></tr></table> | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td></tr><tr><td>MIGS-28</td><td>Libraries used</td><td>IonTorrent 100 bp and 400 bp single end reads</td></tr><tr><td>MIGS-29</td><td>Sequencing platforms</td><td>IonTorrent PGM</td></tr><tr><td>MIGS-31.2</td><td>Fold coverage</td><td>110×</td></tr><tr><td>MIGS-30</... |
5be04b88de8886bfeb707197293157fcf3b814fc515beac21a10fd7768ecdc16.png | complex | <table><tr><td rowspan="2">Clinicopathological features</td><td colspan="4">GPx3 expression level (n)</td></tr><tr><td>Number</td><td>Down regulated</td><td>Non-down regulated</td><td><i>P</i></td></tr><tr><td>Sex</td><td></td><td></td><td></td><td rowspan="3">0.210</td></tr><tr><td> Male</td><td>92</td><td>43</td><td>... | <table><tr><td rowspan="2">Clinicopathological features</td><td>GPx3 expression level (n)</td></tr><tr><td>Number</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>92</td></tr><tr><td>Female</td><td>21</td></tr><tr><td>Age</td><td></td></tr><tr><td>Younger than 55</td><td>57</td></tr><tr><td>Older than 55</td... | <table><tr><td colspan="3">GPx3 expression level (n)</td></tr><tr><td>Down regulated</td><td>Non-down regulated</td><td>P</td></tr><tr><td></td><td></td><td rowspan="3">0.210</td></tr><tr><td>43</td><td>49</td></tr><tr><td>13</td><td>8</td></tr><tr><td></td><td></td><td rowspan="3">0.926</td></tr><tr><td>28</td><td>29<... |
d6f8eea7e40ef304e1f34f809fa0593e9b009adb0e2da1724f5b38dbcdb13944.png | simple | <table><tr><td> </td><td>n</td><td>1 (<=0.90)</td><td>2 (0.91–1.07)</td><td>3 (1.08–1.27)</td><td>4 (>1.27)</td><td>P trend</td></tr><tr><td>Frailty</td><td>30</td><td>1.00</td><td>4.27 (0.66–27.60)</td><td>1.27 (0.22–7.74)</td><td>1.90 (0.36–9.88)</td><td>0.887</td></tr><tr><td>Pre-... | <table><tr><td></td><td>n</td><td>1 (<=0.90)</td><td>2 (0.91–1.07)</td><td>3 (1.08–1.27)</td><td>4 (>1.27)</td><td>P trend</td></tr><tr><td>Frailty</td><td>30</td><td>1.00</td><td>4.27 (0.66–27.60)</td><td>1.27 (0.22–7.74)</td><td>1.90 (0.36–9.88)</td><td>0.887</td></tr><tr><td>Pre-frailty</td><td>79</td><td>1.00</td><... | <table><tr><td>Exhaustion</td><td>43</td><td>1.00</td><td>2.02 (0.66–6.18)</td><td>1.10 (0.34–3.48)</td><td>1.76 (0.63–4.94)</td><td>0.428</td></tr><tr><td>Low hand grip strength</td><td>76</td><td>1.00</td><td>0.86 (0.33–2.28)</td><td>0.34 (0.13–0.88)*</td><td>0.70 (0.27–1.79)</td><td>0.182</td></tr><tr><td>Slow walki... |
46e146b8ef65c99339e0aa2534c52e0f8f5e6e4dc0d462733cf52c63e0a2aae2.png | simple | <table><tr><td>Medicine</td><td>MIC (mg/L)</td></tr><tr><td>AMPH-B</td><td>0.5</td></tr><tr><td>5-FC</td><td><=0.12</td></tr><tr><td>MCZ</td><td>0.12</td></tr><tr><td>FLCZ</td><td>0.25</td></tr><tr><td>ITCZ</td><td>0.06</td></tr><tr><td>MCFG</td><td>0.12</td></tr><tr><td>VRCZ</td><td><=0.015</td></tr></table> | <table><tr><td>Medicine</td><td>MIC (mg/L)</td></tr><tr><td>AMPH-B</td><td>0.5</td></tr><tr><td>5-FC</td><td><=0.12</td></tr><tr><td>MCZ</td><td>0.12</td></tr><tr><td>FLCZ</td><td>0.25</td></tr><tr><td>ITCZ</td><td>0.06</td></tr><tr><td>MCFG</td><td>0.12</td></tr><tr><td>VRCZ</td><td><</td></tr></table> | <table><tr><td>=0.015</td></tr></table> |
bc2cd3122005966407cd9553c8365c9166904a065f7941e8d203d9e94c6b1010.png | simple | <table><tr><td> </td><td> CFC </td><td> WCM </td><td> MRC </td><td> SSC </td><td> RF </td><td> OMCR</td></tr><tr><td>AOM </td><td> 65.6 </td><td> 65.5 </td><td> 61.0 </td><td> 76.2 </td><td> 80.3 </td><td> 90.0 </td></tr><tr><td> OME </td><td> 56.7 </td><td> 58.2 </td><td> 65.3 </td><td> 72.8 </td><td> 79.1 </td><td> 8... | <table><tr><td></td><td>CFC</td><td>WCM</td></tr><tr><td>AOM</td><td>65.6</td><td>65.5</td></tr><tr><td>OME</td><td>56.7</td><td>58.2</td></tr><tr><td>NOE</td><td>71.4</td><td>69.0</td></tr><tr><td>Accuracy</td><td>63.6</td><td>63.6</td></tr></table> | <table><tr><td>MRC</td><td>SSC</td><td>RF</td><td>OMCR</td></tr><tr><td>61.0</td><td>76.2</td><td>80.3</td><td>90.0</td></tr><tr><td>65.3</td><td>72.8</td><td>79.1</td><td>89.1</td></tr><tr><td>83.9</td><td>58.3</td><td>69.4</td><td>93.2</td></tr><tr><td>68.2</td><td>70.0</td><td>77.1</td><td>89.9</td></tr></table> |
32bbe07f75cef1c0d942b89105c0e00339428afa27f526fda15f49677cdcdc17.png | simple | <table><tr><td>Population</td><td>Frequency (%)</td><td>Number of subjects</td><td>Reference</td></tr><tr><td>African American</td><td>20</td><td>50</td><td>[48]</td></tr><tr><td>African American</td><td>36</td><td>85</td><td>[49]</td></tr><tr><td>African American</td><td>34</td><td>93</td><td>[152]</td></tr><tr><td>Ta... | <table><tr><td>Population</td><td>Frequency (%)</td><td>Number of subjects</td><td>Reference</td></tr><tr><td>African American</td><td>20</td><td>50</td><td>[48]</td></tr></table> | <table><tr><td>African American</td><td>36</td><td>85</td><td>[49]</td></tr><tr><td>African American</td><td>34</td><td>93</td><td>[152]</td></tr><tr><td>Tanzanians</td><td>36</td><td>95</td><td>[153]</td></tr><tr><td>Malawians</td><td>∧31 (15)</td><td>26</td><td>[60]</td></tr><tr><td>Ghanaians</td><td>46</td><td>42</t... |
c0a0eb1bb27e1062dbdcf333f3d3aef2e1ac8b0ece93dafb9aeac6e7bb19a9ec.png | complex | <table><tr><td>Study</td><td>n</td><td>n COPD patients</td><td>n controls</td><td>Age (mean ± SD)</td><td>FEV1 (L) (mean ± SD)</td><td>FEV1/FVC% (mean ± SD)</td><td>Pack-years (mean ± SD)</td><td>%Current smoker</td><td>% Female</td></tr><tr><td rowspan="2">Qiu et al.[23]</td><td>1085</td><td>620</t... | <table><tr><td>Study</td><td>n</td><td>n COPD patients</td><td>n controls</td><td>Age (mean ± SD)</td><td>FEV1 (L) (mean ± SD)</td><td>FEV1/FVC% (mean ± SD)</td><td>Pack-years (mean ± SD)</td><td>%Current smoker</td><td>% Female</td></tr><tr><td rowspan="2">Qiu et al.[23]</td><td>1085</td><td>620</td><td>325</td><td>57... | <table><tr><td>. [26]</td><td>3</td><td>7</td><td></td><td>7</td><td>4</td><td>75 ± 8</td><td>24.8</td><td>7</td><td>0</td></tr><tr><td>Marioni et al. [21]</td><td>1091</td><td>N/A</td><td>N/A</td><td>69.8 ± 0.78</td><td>2.36 ± 0.69</td><td>N/A</td><td>N/A</td><td>N/A</td><td>50.4</td></tr><tr><td>Wielscher et al. [24]... |
97a7d65a6abb51c51efce285d7a4a0e4ee2398eda538118b21dd831a39016ea6.png | simple | <table><tr><td>Cultivar</td><td>TDZ/BA concentration</td><td>No. of explants</td><td>% of explants producing massive shoots/buds<sup>x</sup>(mean ± standard error)</td></tr><tr><td>Accent Red</td><td>1 μM TDZ + 0 μM BA (IM1)</td><td>121</td><td>20.5 ± 6.4 A</td></tr><tr><td></td><td>2.3 μM TDZ ... | <table><tr><td>Cultivar</td><td>TDZ/BA concentration</td><td>No. of explants</td><td>% of explants producing massive shoots/budsx(mean ± standard error)</td></tr><tr><td>Accent Red</td><td>1 μM TDZ + 0 μM BA (IM1)</td><td>121</td><td>20.5 ± 6.4 A</td></tr></table> | <table><tr><td></td><td>2.3 μM TDZ + 1.8 μM BA (IM2)</td><td>121</td><td>66.5 ± 6.4 B</td></tr><tr><td></td><td>1 μM TDZ + 2.2 μM BA (IM3)</td><td>119</td><td>42.6 ± 6.4 C</td></tr><tr><td>Salmon</td><td>1 μM TDZ + 0 μM BA (IM1)</td><td>65</td><td>59.5 ± 5.3 A</td></tr><tr><td>Picote</td><td>2.3 μM TDZ + 1.8 μM BA (IM2... |
1ad0520b05744b4ceeb9e047ce2bd3cf5fa7fb778b19b0be64944392cb258392.png | simple | <table><tr><td> </td><td> </td><td>F<sub>ST</sub></td><td>mAI<sub>C</sub></td><td>vAI<sub>C</sub></td><td>mPr</td></tr><tr><td>Clusters 3 & 4</td><td>F (202)</td><td>0.028</td><td>0.476</td><td>20.05</td><td>0.031</td></tr><tr><td> </td><td>M (179)</td><td>0.028</td><td>−0.537</td><td>17.20</td><td>0.033</td>... | <table><tr><td></td><td></td><td>FST</td><td>mAIC</td><td>vAIC</td><td>mPr</td></tr><tr><td>Clusters 3 & 4</td><td>F (202)</td><td>0.028</td><td>0.476</td><td>20.05</td><td>0.031</td></tr><tr><td></td><td>M (179)</td><td>0.028</td><td>−0.537</td><td>17.20</td><td>0.033</td></tr><tr><td></td><td>P-value</td><td>0.991</t... | <table><tr><td>Cluster 1</td><td>F (61)</td><td>0.020</td><td>0.541</td><td>17.19</td><td>0.099</td></tr><tr><td></td><td>M (44)</td><td>0.013</td><td>−0.750</td><td>35.52</td><td>0.252</td></tr><tr><td></td><td>P-value</td><td>0.931</td><td>0.144</td><td>0.033</td><td>0.000</td></tr></table> |
49b7f9085c970bf95d3a7c863ea3d36cae5788cda424b05c25d3a043a6a5965a.png | complex | <table><tr><td rowspan="2"></td><td colspan="6">SITE</td></tr><tr><td>NHA, <i>n</i> (%)</td><td>UATH, <i>n</i> (%)</td><td>MCHO, <i>n</i> (%)</td><td>GHA, <i>n</i> (%)</td><td>FMCK, <i>n</i> (%)</td><td>AKTH, <i>n</i> (%)</td></tr><tr><td>SCREENED, 5190</td><td>1979 (38.1)</td><td>1792 (34.5)</td><td>539 (10.4)</td><td... | <table><tr><td rowspan="2"></td><td colspan="6">SITE</td></tr><tr><td>NHA, n (%)</td><td>UATH, n (%)</td><td>MCHO, n (%)</td><td>GHA, n (%)</td><td>FMCK, n (%)</td><td>AKTH, n (%)</td></tr><tr><td>SCREENED, 5190</td><td>1979 (38.1)</td><td>1792 (34.5)</td><td>539 (10.4)</td><td>352 (6.8)</td><td>393 (7.6 %)</td><td>135... | <table><tr><td rowspan="2"></td><td colspan="6">SITE</td></tr><tr><td>NHA, n (%)</td><td>UATH, n (%)</td><td>MCHO, n (%)</td><td>GHA, n (%)</td><td>FMCK, n (%)</td><td>AKTH, n (%)</td></tr><tr><td>HIV Positive = 120, n (%)</td><td>79 (65.8)</td><td>38 (31.7)</td><td>1 (0.8)</td><td>2 (1.7)</td><td>0 (0.0)</td><td>0 (0.... |
48be76e5efa5ccec4a6cd02e1cf0cca8ae608eb78cfbcb323699911155b90bbf.png | complex | <table><tr><td></td><td colspan="3">Men (N = 2389)</td><td colspan="3">Women (N = 2328)</td><td></td></tr><tr><td></td><td>n</td><td>%</td><td>%w</td><td>n</td><td>%</td><td>%w</td><td>p</td></tr><tr><td>Covariates in 2006</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Age (years)</td><... | <table><tr><td></td><td colspan="3">Men (N = 2389)</td><td colspan="3">Women (N = 2328)</td><td></td></tr><tr><td></td><td>n</td><td>%</td><td>%w</td><td>n</td><td>%</td><td>%w</td><td>p</td></tr><tr><td>Covariates in 2006</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Age (years)</td><... | <table><tr><td>Occupation</td><td></td><td></td><td></td><td></td><td></td><td></td><td>***</td></tr><tr><td>Managers/professionals</td><td>401</td><td>16.80</td><td>16.66</td><td>318</td><td>13.67</td><td>11.86</td><td></td></tr><tr><td>Associate professionals/technicians</td><td>602</td><td>25.22</td><td>25.71</td><t... |
8bdaffaecb19c02d7faef5e2ae3a535af7a14c31ef0260bfeb06bd2fb0c26563.png | complex | <table><tr><td>The Value of <i>L</i> (mm)</td><td>Strength of the Alternating Magnetic Field (A/m)</td><td>Compensation Ratio of <i>V<sub>pp</sub></i></td><td colspan="2"><i>f<sub>L</sub></i> (kHz)</td><td colspan="2"><i>f</i><i><sub>n</sub></i>(kHz)</td><td colspan="2">Relative Tolerance</td></tr><tr><td>20</td><td>68... | <table><tr><td>The Value of L (mm)</td><td>Strength of the Alternating Magnetic Field (A/m)</td><td>Compensation Ratio of Vpp</td><td colspan="2">fL (kHz)</td><td colspan="2">fn(kHz)</td><td colspan="2">Relative Tolerance</td><td></td></tr><tr><td>20</td><td>6892</td><td colspan="2">1.11</td><td colspan="2">-</td><td c... | <table><tr><td>The Value of L (mm)</td><td>Strength of the Alternating Magnetic Field (A/m)</td><td>Compensation Ratio of Vpp</td><td colspan="2">fL (kHz)</td><td colspan="2">fn(kHz)</td><td colspan="2">Relative Tolerance</td><td></td></tr><tr><td>30</td><td>7499</td><td colspan="2">1.02</td><td colspan="2">140</td><td... |
d9dbf69915ef697e34fc592bc0557be3eb8b2abeccd8ba07cdc6535239a30293.png | complex | <table><tr><td colspan="2"></td><td>IM</td><td>GS</td><td>OBGY</td><td>Ped</td><td>Psy</td><td>OS</td><td>EM</td><td>Total</td></tr><tr><td>History Taking</td><td>Min</td><td>2</td><td>0</td><td>0</td><td>1</td><td>1</td><td>0</td><td>0</td><td>5</td></tr><tr><td></td><td>Max</td><td>30</td><td>30</td><td>10</td><td>16... | <table><tr><td colspan="2"></td><td>IM</td><td>GS</td><td>OBGY</td><td>Ped</td><td>Psy</td><td>OS</td><td>EM</td><td>Total</td></tr><tr><td>History Taking</td><td>Min</td><td>2</td><td>0</td><td>0</td><td>1</td><td>1</td><td>0</td><td>0</td><td>5</td></tr><tr><td></td><td>Max</td><td>30</td><td>30</td><td>10</td><td>16... | <table><tr><td></td><td>Max</td><td>30</td><td>20</td><td>10</td><td>16</td><td>12</td><td>20</td><td>10</td><td>85</td></tr><tr><td></td><td>Mean</td><td>12.9</td><td>7.9</td><td>2.5</td><td>4.5</td><td>3.6</td><td>1.7</td><td>2.3</td><td>35.4</td></tr><tr><td></td><td>SD</td><td>5.4</td><td>5.2</td><td>2.6</td><td>2.... |
a1d5ce78771b1d2359ac5e01c8f1d1f7e519cc2f9b7f7260d26efef1ad2421cf.png | simple | <table><tr><td>Manner of intent <sup>a,b</sup></td><td>Total N (%)</td><td>Mean</td><td>Std. Dev.</td><td>Min</td><td>Max</td></tr><tr><td>Total firearm deaths</td><td>5,660 (100)</td><td>138.1</td><td>43.5</td><td>67</td><td>243</td></tr><tr><td> Accidental</td><td>164 (2.9)</td><td>4</td><td>3.2</td><td>-</td><td>11<... | <table><tr><td>Manner of intent a,b</td><td>Total N (%)</td><td>Mean</td><td>Std. Dev.</td><td>Min</td><td>Max</td></tr><tr><td>Total firearm deaths</td><td>5,660 (100)</td><td>138.1</td><td>43.5</td><td>67</td><td>243</td></tr><tr><td>Accidental</td><td>164 (2.9)</td><td>4</td><td>3.2</td><td>-</td><td>11</td></tr><tr... | <table><tr><td>Manner of intent a,b</td><td>Total N (%)</td><td>Mean</td><td>Std. Dev.</td><td>Min</td><td>Max</td></tr><tr><td>Suicide a</td><td>4,863 (91.2)</td><td>118.6</td><td>37.9</td><td>54</td><td>199</td></tr><tr><td>Homicide a</td><td>276 (5,2)</td><td>6.7</td><td>3.6</td><td>1</td><td>15</td></tr><tr><td>Eve... |
66f209bae12e4f11c90b7e1ec94d93a2bb8f5a97c4ca58703dfea58186f9247a.png | simple | <table><tr><td></td><td>Dapagliflozin N = 10 227</td><td>DPP‐4 inhibitor N = 30 681</td><td>Standardized differencea</td></tr><tr><td>Age, years (s.d.)</td><td>61 (11.1)</td><td>60.8 (12.4)</td><td>0.017</td></tr><tr><td>Sex (Female)</td><td>4196 (41.0)</td><td>12 391 (40.4)</td><td>0.011</td></tr><tr><td>First G... | <table><tr><td></td><td>Dapagliflozin N = 10 227</td><td>DPP‐4 inhibitor N = 30 681</td><td>Standardized differencea</td></tr><tr><td>Age, years (s.d.)</td><td>61 (11.1)</td><td>60.8 (12.4)</td><td>0.017</td></tr><tr><td>Sex (Female)</td><td>4196 (41.0)</td><td>12 391 (40.4)</td><td>0.011</td></tr><tr><td>First GLD, ye... | <table><tr><td>Loop diuretics</td><td>1364 (13.3)</td><td>4036 (13.2)</td><td>0.004</td></tr><tr><td>Aldosteron antagonists</td><td>441 (4.3)</td><td>1303 (4.2)</td><td>0.003</td></tr><tr><td>Warfarin</td><td>527 (5.2)</td><td>1530 (5.0)</td><td>0.006</td></tr><tr><td>Receptor P2Y12 antagonists</td><td>471 (4.6)</td><t... |
99018e18a6f6327763b224f2a88c5d0a5d38ad38879a22c3de7cd37b0d33f0ef.png | complex | <table><tr><td rowspan="2">Variable</td><td>Premetformin</td><td>Postmetformin</td><td>Change</td><td><i>P</i>-value</td></tr><tr><td>Median (Q1, Q3)</td><td>Median (Q1, Q3)</td><td>Median (Q1, Q3)</td><td></td></tr><tr><td>Insulin receptor</td><td>4.5 (3, 6)</td><td>4 (2, 5)</td><td>0 (−1, 0)</td><td>0.0375</td>... | <table><tr><td>Variable</td><td>Premetformin</td><td>Postmetformin</td><td>Change</td><td>P-value</td></tr></table> | <table><tr><td>Variable</td><td>Median (Q1, Q3)</td><td>Median (Q1, Q3)</td><td>Median (Q1, Q3)</td><td></td></tr><tr><td>Insulin receptor</td><td>4.5 (3, 6)</td><td>4 (2, 5)</td><td>0 (−1, 0)</td><td>0.0375</td></tr><tr><td>OCT1</td><td>ND</td><td>7 (6, 7)</td><td>ND</td><td>ND</td></tr><tr><td>Cytoplasmic p-Akt (S473... |
bd87ed45405da0250964a37cdf3dc8c7165e6d54e370931122de5ba6137e5155.png | simple | <table><tr><td>Gene Description</td><td>Unigene</td><td>Gene Bank</td><td>Function</td></tr><tr><td>Cadherin 5, type 2, VE-cadherin</td><td>Hs.76206</td><td>NM_001795</td><td>Plays an important role in cell adhesion and is crucial for vessel growth and maturation.</td></tr><tr><td>Collagen, type XVIII, alpha 1</td><td>... | <table><tr><td>Gene Description</td><td>Unigene</td><td>Gene Bank</td><td>Function</td></tr><tr><td>Cadherin 5, type 2, VE-cadherin</td><td>Hs.76206</td><td>NM_001795</td><td>Plays an important role in cell adhesion and is crucial for vessel growth and maturation.</td></tr><tr><td>Collagen, type XVIII, alpha 1</td><td>... | <table><tr><td>Gene Description</td><td>Unigene</td><td>Gene Bank</td><td>Function</td></tr><tr><td>Collagen, type IV, alpha 3</td><td>Hs.570065</td><td>NM_000091</td><td></td></tr><tr><td>Integrin, alpha V</td><td>Hs.436873</td><td>NM_002210</td><td>Cell adhesion molecules that plays a key role in tumor growth, angiog... |
d50f41df039fe9943a4c5b402af89f7261b3a4ca020f515b346461ac5225a7aa.png | simple | <table><tr><td>Original data</td><td>Secret data</td><td>XOR result</td></tr><tr><td>0</td><td>0</td><td>0</td></tr><tr><td>0</td><td>1</td><td>1</td></tr><tr><td>1</td><td>0</td><td>1</td></tr><tr><td>1</td><td>1</td><td>0</td></tr></table> | <table><tr><td>Original data</td><td>Secret data</td><td>XOR result</td></tr></table> | <table><tr><td>0</td><td>0</td><td>0</td></tr><tr><td>0</td><td>1</td><td>1</td></tr><tr><td>1</td><td>0</td><td>1</td></tr><tr><td>1</td><td>1</td><td>0</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.